» Publications

SCI-SSCI or SCI Expanded Articles

.ALP KIRKIZLAR TUGCAN, KIRKIZLAR HAKKI ONUR, DEMIRCI UFUK, AYTUG UMUT, IFLAZOGLU HÜSEYIN, ÜMIT ELIF GÜLSÜM, DEMIR AHMET MUZAFFER, Incidence and predisposing factors of infection in patients treated with hypomethylating agents, Leukemia Research, vol. 127, no. 107043, pp. 1-6, 2023. (February 2023)

2
ATIF

.KIRKIZLAR HAKKI ONUR, ÇELIK MEHMET, Therapeutic plasma exchange in hyperthyroidism prior to surgery, Journal of Endocrinological Investigation, vol. 46, no. 46, pp. 173-179, 2023. (January 2023)

2
ATIF

.KIRKIZLAR HAKKI ONUR, ÇELIK MEHMET, Therapeutic plasma exchange in hyperthyroidism prior to surgery, Journal of Endocrinological Investigation, vol. 46, no. 46, pp. 173-179, 2023.

The first case of peripheral T cell lyphoma with a CSF3R variant resulted in relapsing febrile neutropenia and aplastic anemia (September 2022)

s12308-022-00513-8.pdf

Therapeutic plasma exchange in hyperthyroidism prior to surgery (August 2022)
s40618-022-01897-1.pdf
Castleman Disease: A Multicenter Case Series from Turkey (June 2022)
TJH_39_2_130_135.pdf

Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?, BAYSAL MEHMET, BAS VOLKAN, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Turkish Journal of Hematology, vol. 39, no. 1, pp. 38-42, 2022 (March 2022)

3
ATIF

ATIFLAR

Title: Efficacy and safety of azathioprine plus prednisone versus prednisone alone as first-line treatment for antinuclear antibody-positive immune thrombocytopenia: a retrospective cohort study Author(s): Su, JN (Su, Junnan); Xu, MH (Xu, Meihong); Dong, ZG (Dong, Zhigao); Wang, QQ (Wang, Qingqing); Ma, LL (Ma, Lili); Xiao, PP (Xiao, Pingping); Chen, XY (Chen, Xuyan) Source: HEMATOLOGY Volume: 28 Issue: 1 Article Number: 2196864 DOI: 10.1080/16078454.2023.2196864 Published: DEC 31 2023 Accession Number: WOS:000962950500001 (December 2023)
Title: Frequency and Clinical Significance of Antinuclear Antibody Positivity in Immune Thrombocytopenia in Adults Author(s): Ali, RM (Munawar Ali, Rabeea); Zafar, S (Zafar, Sidra); Abid, M (Abid, Madiha); Butt, AJ (Javed Butt, Aqsa); Ali, MS (Ali, Muhammad Shujat); Borhany, M (Borhany, Munira) Source: PLASMATOLOGY Volume: 17 Article Number: 26348535231165594 DOI: 10.1177/26348535231165594 Published: 2023 Accession Number: WOS:000955630800001 (April 2023)
Title: Novel Biomarkers for Diagnosis and Monitoring of Immune Thrombocytopenia Author(s): Allegra, A (Allegra, Alessandro); Cicero, N (Cicero, Nicola); Mirabile, G (Mirabile, Giuseppe); Giorgianni, CM (Giorgianni, Concetto Mario); Gangemi, S (Gangemi, Sebastiano) Source: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES Volume: 24 Issue: 5 Article Number: 4438 DOI: 10.3390/ijms24054438 Published: MAR 2023 Accession Number: WOS:000947412700001 (March 2023)

Patient characteristics and management practices in chronic myeloid leukemia in Turkey: reflections from an expert meeting. (March 2022)

3
ATIF

The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study. (February 2022)

s00277-022-04798-8.pdf

1
ATIF

.DEMIRCI UFUK, KIRKIZLAR HAKKI ONUR, ÜMIT ELIF GÜLSÜM, GÜRSOY VILDAN, PINAR IBRAHIM ETHEM, ÖZKALEMKAS FAHIR, GÜVEN ZEYNEP TUGBA, KAYNAR LEYLAGÜL, KEKLIK KARADAG FATMA, SAYDAM GÜRAY, EKINCI ÖMER, MERTER MUSTAFA, REIS ARAS MERIH, ALBAYRAK MURAT, KARAMAN GÜLSARAN SEDANUR, BAS VOLKAN, BALIK AYDIN BERRIN, BEKÖZ HÜSEYIN SAFFET, CAN FERDA, IMDAT DILEK, MEHTAP ÖZGÜR, ÖZTÜRK ERMAN, ÇOBANOGLU SIMSEK BENGÜ, YILDIRIM MURAT, AYLI MELTEM, ATAS ÜNAL, SALIM OZAN, AYER MESUT, BIRTAS ATESOGLU ELIF, AKAY OLGA MELTEM, YÜKSEL MELTEM, PAYDAS SEMRA, KORKMAZ SELÇUK, ÖZ PUYAN FULYA, DEMIR AHMET MUZAFFER, CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study, Journal of Hematopathology, vol. 15, pp. 203-213, 2022.

.GÜNDÜZ EREN, KIRKIZLAR HAKKI ONUR, ÜMIT ELIF GÜLSÜM, KARAMAN GÜLSARAN SEDANUR, ÖZKOCAMAN VILDAN, ÖZKALEMKAS FAHIR, CANDAR ÖMER, ELVERDI TUGRUL, KÜÇÜKYURT KAYA SELIN, PAYDAS SEMRA, ÇENELI ÖZCAN, KARAKUS SEMA, MARAL SENEM, EKINCI ÖMER, IPEK YILDIZ, KIS CEM, GÜVEN ZEYNEP TUGBA, AKDENIZ AYDAN, CELKAN TÜLIN TIRAJE, EROGLU KÜÇÜKDILER AYSE HILAL, AKGÜN ÇAGLIYAN GÜLSÜM, ÖZÇELIK SENGÖZ CEYDA, KARATAS AYSE, BULDUK TUBA, ÖZCAN ALPER, BELEN APAK FATMA BURCU, CANBOLAT AYHAN AYLIN, KARTAL IBRAHIM, ÖREN HALE, TÖRET ERSIN, ÖZDEMIR GÜL NIHAL, BAKANAY ÖZTÜRK SULE MINE, Castleman Disease: A Multicenter Case Series from Turkey, Turkish Journal of Hematology, vol. 39, no. 2, pp. 130-135, 2022.

.BAYSAL MEHMET, GÜRSOY VILDAN, HUNUTLU FAZIL ÇAGRI, ERKAN ÖZMARASALI BUKET, DEMIRCI UFUK, BAS VOLKAN, KARAMAN GÜLSARAN SEDANUR, PINAR IBRAHIM ETHEM, ERSAL TUBA, ALP KIRKIZLAR TUGCAN, ATLI EMINE IKBAL, KIRKIZLAR HAKKI ONUR, ÜMIT ELIF GÜLSÜM, GÜRKAN HAKAN, ÖZKOCAMAN VILDAN, ÖZKALEMKAS FAHIR, DEMIR AHMET MUZAFFER, ALI RIDVAN, The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study, Annals of Hematology, vol. 101, no. 5, pp. 1049-1057, 2022.

.ESKAZAN AHMET EMRE, ALI RIDVAN, ALNIGENIS EBRU, AYYILDIZ MEHMET ORHAN, HAZNEDAROGLU IBRAHIM CELALETTIN, KIRKIZLAR HAKKI ONUR, KURTOGLU ERDAL, MALHAN BERNA SIMTEN, ÖKSÜZ MEHMET ERGUN, POLAT ÖZLEM, SAYDAM GÜRAY, SÖNMEZ MEHMET, TOPRAK SELAMI KOÇAK, TOPTAS TAYFUR, TURGUT MEHMET, Patient characteristics and management practices in chronic myeloid leukemia in Turkey: reflections from an expert meeting, Expert Review of Hematology, vol. 15, no. 2, pp. 97-106, 2022.

.KIRKIZLAR HAKKI ONUR, CAN NURAY, The first case of peripheral T cell lyphoma with a CSF3R variant resulted in relapsing febrile neutropenia and aplastic anemia, Journal of Hematopathology, vol. 15, pp. 245-248, 2022.

.BAYSAL MEHMET, BAS VOLKAN, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?, Turkish Journal of Hematology, vol. 39, no. 1, pp. 38-42, 2022.

The Utility of CONUT Score in Diffuse Large B Cell Lymphoma Patients, Nigerian Journal of Clinical Practice, vol. 24, no. 8, pp. 1194-1199, 2021. (August 2021)

8
ATIF

ATIFLAR

Integrative Approaches in the Treatment of Patients Affected by Lymphoma DOI10.1007/s11912-023-01476-4 CURRENT ONCOLOGY REPORTS (December 2023)
Assessment of nutritional status and clinical outcomes: A comprehensive retrospective analysis of critically ill patients DOI10.1097/MD.0000000000036018 MEDICINE (November 2023)
The prognostic value of controlling nutritional status (CONUT) score-based nomogram on extranodal natural killer/T cell lymphoma patients DOI10.1007/s00277-023-05232-3 ANNALS OF HEMATOLOGY (June 2023)
Prognostic role of controlling nutritional status score in hematological malignancies Author(s): Zhang, YJ (Zhang, Yijing); Chen, QN (Chen, Qiuni); Lu, CY (Lu, Chuanyang); Yu, L (Yu, Liang) Source: HEMATOLOGY Volume: 27 Issue: 1 Pages: 653-658 DOI: 10.1080/16078454.2022.2078040 Published: DEC 31 2022 Abstract: Background Controlling nutritional status (CONUT) score, based on three indexes including serum albumin (ALB), total cholesterol (CHO), and absolute lymphocyte count (ALC), has been closely associated with the prognosis of cancer patients. Multiple studies revealed the significance of CONUT score in hematological malignancies, including diffuse large B-cell lymphoma (DLBCL), peripheral T-cell lymphoma (PTCL), multiple myeloma (MM), and leukemia. Objective This review aimed to explore the prognostic role of CONUT score in hematological malignancies. Methods We conducted this review through Pubmed to summarize the published studies on the CONUT score in hematological malignancies, using the terms: Controlling nutritional status, CONUT score, hematological malignancy, lymphoma, multiple myeloma, and leukemia. Result CONUT score can reflect not only the nutritional status but also the inflammatory status of patients with hematological malignancies. It can assist in predicting the survival of patients with DLBCL, PTCL, MM, adult Tcell leukemia (ATL), myelodysplastic syndrome (MDS), and acute myeloid leukemia with myelodysplasia related changes (AML-MRC). Conclusion CONUT score plays an important role in predicting the prognosis of patients with hematological malignancies. Accession Number: WOS:000800687800001 PubMed ID: 35622088 ISSN: 1024-5332 eISSN: 1607-8454 (December 2022)
Prognostic value of nutritional status in patients with human immunodeficiency virus infection-related lymphoma Author(s): Liu, TT (Liu, TingTing); Hu, RZ (Hu, RenZhi); Lv, J (Lv, Jing); Luo, Q (Luo, Qin); Xu, LX (Xu, LuXiang); Wang, CY (Wang, ChaoYu); Liu, J (Liu, Jun); Yang, ZL (Yang, ZaiLin); Xu, LL (Xu, LingLi); Liu, Y (Liu, Yao) Source: FRONTIERS IN NUTRITION Volume: 9 Article Number: 1050139 DOI: 10.3389/fnut.2022.1050139 Published: NOV 10 2022 (November 2022)
Controlling Nutritional Status (CONUT) Score and Sarcopenia as Mutually Independent Prognostic Biomarkers in Advanced Urothelial Carcinoma Author(s): Une, M (Une, Minami); Ito, M (Ito, Masaya); Suzuki, H (Suzuki, Hiroaki); Toide, M (Toide, Masahiro); Kobayashi, S (Kobayashi, Shuichiro); Fukushima, H (Fukushima, Hiroshi); Koga, F (Koga, Fumitaka) Source: CANCERS Volume: 14 Issue: 20 Article Number: 5075 DOI: 10.3390/cancers14205075 Published: OCT 2022 (October 2022)
Prognostic impact of the controlling nutritional status score in patients with hematologic malignancies: A systematic review and meta-analysis Author(s): Lu, CY (Lu, Chuanyang); Chen, QN (Chen, Qiuni); Fei, LR (Fei, Linrong); Wang, JH (Wang, Junhui); Wang, CL (Wang, Chunling); Yu, L (Yu, Liang) Source: FRONTIERS IN IMMUNOLOGY Volume: 13 Article Number: 952802 DOI: 10.3389/fimmu.2022.952802 Published: OCT 5 2022 (October 2022)
The Value of Prognostic Nutritional Index (PNI) on Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients: A Multicenter Retrospective Study of HHLWG Based on Propensity Score Matched Analysis (November 2021)

.BAYSAL MEHMET, BAS VOLKAN, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Could Anti-Nuclear Antibody Positivity be a Factor for Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?, Turkish Journal of Hematology, 2021. (June 2021)

Sarcopenia in Hodgkin’s lymphoma evaluated with 18-FDG PET/CT, focus on age, performance, and treatment, SUPPORTIVE CARE IN CANCER, vol. 29, no. 5, pp. 2475-2480, 2021. (May 2021)

3
ATIF

Pros and cons for fluorescent in situ hybridization, karyotyping and next generation sequencing for diagnosis and follow-up of multiple myeloma, Balkan Journal of Medical Genetics, vol. 23, no. 2, pp. 59-64, 2021. (March 2021)

1
ATIF

THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES , Mediterranean Journal of Hematology and Infectious Diseases, vol. 13, no. 1, pp. 1-10, 2021. (January 2021)

3
ATIF

ATIFLAR

Genetic mutations associated with blood count abnormalities in myeloid neojiasms Author(s): Polprasert, C (Polprasert, Chantana); Kongkiatkamon, S (Kongkiatkamon, Sunisa); Niparuck, P (Niparuck, Pimjai); Rattanathammethee, T (Rattanathammethee, Thanawat); Wudhikarn, K (Wudhikarn, Kitsada); Chuncharunee, S (Chuncharunee, Suporn); Kobbuaklee, S (Kobbuaklee, Sirorat); Suksusut, A (Suksusut, Amornchai); Lanamtieng, T (Lanamtieng, Theerin); Lawasut, P (Lawasut, Panisinee); Asawapanumas, T (Asawapanumas, Thiti); Bunworasate, U (Bunworasate, Udomsak); Rojnuckarin, P (Rojnuckarin, Ponlapat) Source: HEMATOLOGY Volume: 27 Issue: 1 Pages: 765-771 DOI: 10.1080/16078454.2022.2094134 Published: DEC 31 2022 (December 2022)
Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms Author(s): Polprasert, C (Polprasert, Chantana); Niparuck, P (Niparuck, Pimjai); Rattanathammethee, T (Rattanathammethee, Thanawat); Kobbuaklee, S (Kobbuaklee, Sirorat); Lanamtieng, T (Lanamtieng, Theerin); Rojnuckarin, P (Rojnuckarin, Ponlapat) Source: HEMATOLOGY Volume: 27 Issue: 1 Pages: 1294-1297 DOI: 10.1080/16078454.2022.2156682 Published: DEC 31 2022 (December 2022)
Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations Author(s): Polprasert, C (Polprasert, Chantana); Niparuck, P (Niparuck, Pimjai); Rattanathammethee, T (Rattanathammethee, Thanawat); Chuncharunee, S (Chuncharunee, Suporn); Kobbuaklee, S (Kobbuaklee, Sirorat); Songserm, K (Songserm, Kritanan); Suksusut, A (Suksusut, Amornchai); Trithiphen, S (Trithiphen, Sasinipa); Lanamtieng, T (Lanamtieng, Theerin); Kongkiatkamon, S (Kongkiatkamon, Sunisa); Chanswangphuwana, C (Chanswangphuwana, Chantiya); Lawasut, P (Lawasut, Panisinee); Bunworasate, U (Bunworasate, Udomsak); Rojnuckarin, P (Rojnuckarin, Ponlapat) Source: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA Volume: 22 Issue: 5 Pages: E293-E299 DOI: 10.1016/j.clml.2021.10.015 Early Access Date: APR 2022 Published: MAY 2022 (May 2022)

Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia, 10.4274/tjh.galenos.2020.2020.0348, TURKISH JOURNAL OF HEMATOLOGY, vol. 38, no. 1, pp. 64-68, 2021. (January 2021)

6
ATIF

ATIFLAR

Laboratory investigation and diagnosis of thrombotic thrombocytopenic purpura CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES Volume: 60 Issue: 8 Pages: 625-639 DOI: 10.1080/10408363.2023.2232039 Early Access Date: JUL 2023 Published: NOV 17 2023 (November 2023)
Challenges in the diagnosis of thrombotic thrombocytopenic purpura DOI10.1080/17474086.2023.2265058 EXPERT REVIEW OF HEMATOLOGY (November 2023)
Potential modifications of the PLASMIC scoring system for predicting thrombotic thrombocytopenic purpura: Sometimes, less is more INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY Volume: 45 Issue: 5 Pages: 751-757 DOI: 10.1111/ijlh.14115 Early Access Date: JUN 2023 Published: OCT 2023 (October 2023)
Clinical features and neurological outcomes in pediatric immune-mediated thrombotic thrombocytopenic purpura: A report from a large pediatric hematology center Author(s): Graciaa, S (Graciaa, Sara); Adeagbo, S (Adeagbo, Segun); Fong, G (Fong, Grace); Rollins, M (Rollins, Margo); McElfresh, P (McElfresh, Patricia); Zerra, PE (Zerra, Patricia E.); Bennett, C (Bennett, Carolyn); Josephson, CD (Josephson, Cassandra D.); Briones, M (Briones, Michael); Fasano, RM (Fasano, Ross M.); Chonat, S (Chonat, Satheesh) Source: PEDIATRIC BLOOD & CANCER Volume: 69 Issue: 12 Article Number: e29992 DOI: 10.1002/pbc.29992 Early Access Date: SEP 2022 Published: DEC 2022 (December 2022)
Application of PLASMIC Score in Risk Prediction of Thrombotic Thrombocytopenic Purpura: Real-World Experience From a Tertiary Medical Center in Taiwan Author(s): Lee, CH (Lee, Chun-Hui); Huang, YC (Huang, Yi-Ching); Li, SS (Li, Sin-Syue); Hsu, YT (Hsu, Ya-Ting); Chen, YP (Chen, Ya-Ping); Chen, TY (Chen, Tsai-Yun) Source: FRONTIERS IN MEDICINE Volume: 9 Article Number: 893273 DOI: 10.3389/fmed.2022.893273 Published: MAY 9 2022 (May 2022)
Molecular Diagnosis Is Vital to the Accurate Classification and Management of Thrombotic Thrombocytopenic Purpura in Children Author(s): Karsenty, CL (Karsenty, Cecile L.); Kirk, SE (Kirk, Susan E.); Helber, HL (Helber, Hannah L.); Esquilin, JM (Esquilin, Jose M.); Despotovic, JM (Despotovic, Jenny M.); Grimes, AB (Grimes, Amanda B.) Source: FRONTIERS IN IMMUNOLOGY Volume: 13 Article Number: 836960 DOI: 10.3389/fimmu.2022.836960 Published: APR 11 2022 (April 2022)

.BAYSAL MEHMET, BAS VOLKAN, DEMIRCI UFUK, KARAMAN GÜLSARAN SEDANUR, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, The Utility of CONUT Score in Diffuse Large B Cell Lymphoma Patients, Nigerian Journal of Clinical Practice, vol. 24, no. 8, pp. 1194-1199, 2021.

.BAS VOLKAN,ÜMIT ELIF GÜLSÜM,KORKMAZ ÜLKÜ,BAYSAL MEHMET,KARAMAN GÜLSARAN SEDANUR,DEMIRCI UFUK,KIRKIZLAR HAKKI ONUR,ALTUN GÜLAY,DEMIR AHMET MUZAFFER, Sarcopenia in Hodgkin’s lymphoma evaluated with 18-FDG PET/CT, focus on age, performance, and treatment, SUPPORTIVE CARE IN CANCER, vol. 29, no. 5, pp. 2475-2480, 2021.

.BAYSAL MEHMET, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia, Turkish Journal of Hematology, vol. 38, no. 1, pp. 64-68, 2021.

Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia, T. Kirkizlar, H. Akalin, O. Kirkizlar, F. Ozkalemkas, V. Ozkocaman, E. Kazak, C. Ozakin, E. Bulbul, E. Ozboz, R. Ali, 10.1016/j.leukres.2020.106463, LEUKEMIA RESEARCH, vol. 99, pp. , 2020 (December 2020)

3
ATIF

ATIFLAR

Title: Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis Author(s): Eichel, VM (Eichel, V. M.); Last, K (Last, K.); Brühwasser, C (Bruhwasser, C.); von Baum, H (von Baum, H.); Dettenkofer, M (Dettenkofer, M.); Göetting, T (Gotting, T.); Grundmann, H (Grundmann, H.); Güeldenhöeven, H (Guldenhoven, H.); Liese, J (Liese, J.); Martin, M (Martin, M.); Papan, C (Papan, C.); Sadaghiani, C (Sadaghiani, C.); Wendt, C (Wendt, C.); Werner, G (Werner, G.); Mutters, NT (Mutters, N. T.) Source: JOURNAL OF HOSPITAL INFECTION Volume: 141 Pages: 119-128 DOI: 10.1016/j.jhin.2023.09.008 Early Access Date: OCT 2023 Published: NOV 2023 Accession Number: WOS:001100032800001 (November 2023)
Title: Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study Author(s): Meschiari, M (Meschiari, Marianna); Kaleci, S (Kaleci, Shaniko); Del Monte, M (Del Monte, Martina); Dessilani, A (Dessilani, Andrea); Santoro, A (Santoro, Antonella); Scialpi, F (Scialpi, Francesco); Franceschini, E (Franceschini, Erica); Orlando, G (Orlando, Gabriella); Cervo, A (Cervo, Adriana); Monica, M (Monica, Morselli); Forghieri, F (Forghieri, Fabio); Venturelli, C (Venturelli, Claudia); Ricchizzi, E (Ricchizzi, Enrico); Chester, J (Chester, Johanna); Sarti, M (Sarti, Mario); Guaraldi, G (Guaraldi, Giovanni); Luppi, M (Luppi, Mario); Mussini, C (Mussini, Cristina) Source: ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL Volume: 12 Issue: 1 Article Number: 126 DOI: 10.1186/s13756-023-01332-x Published: NOV 13 2023 Accession Number: WOS:001101622600001 (November 2023)
Title: Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models Author(s): Danielsen, AS (Danielsen, Anders Skyrud); Franconeri, L (Franconeri, Lea); Page, S (Page, Samantha); Myhre, AE (Myhre, Anders Eivind); Tornes, RA (Tornes, Ragnhild Agathe); Kacelnik, O (Kacelnik, Oliver); Bjornholt, JV (Bjornholt, Jorgen Vildershoj) Source: BMC INFECTIOUS DISEASES Volume: 23 Issue: 1 Article Number: 247 DOI: 10.1186/s12879-023-08182-3 Published: APR 18 2023 Accession Number: WOS:000974817800012 (April 2023)

A case of refractory chronic lymphocytic leukaemia with an unusual course Umit EG, Baysal M, Ozdöver AC, Kirkizlar O, Demir AM. A case of refractory chronic lymphocytic leukaemia with an unusual course. Natl Med J India [serial online] 2019 [cited 2021 Feb 7];32:347-9. Available from: http://www.nmji.in/text.asp?2019/32/6/347/303614 (December 2020)

Evaluation of Sarcopenia with F-18 FDG PET/CT and relation with disease outcomes in patients with multiple myeloma, E. Umit, U. Korkmaz, M. Baysal, S. Karaman Gulsaran, V. Bas, U. Demirci, H. Onur Kirkizlar, G. Durmus Altun, A. Muzaffer Demir, 10.1111/ecc.13318, EUROPEAN JOURNAL OF CANCER CARE, vol. 29, no. 6, pp. , 2020 (September 2020)

4
ATIF

.V. Bas, E. Umit, U. Korkmaz, M. Baysal, S. Karaman Gulsaran, U. Demirci, H. Kirkizlar, G. Durmus Altun, A. Demir, Sarcopenia in Hodgkin's lymphoma evaluated with 18-FDG PET/CT, focus on age, performance, and treatment, 10.1007/s00520-020-05772-8, SUPPORTIVE CARE IN CANCER, pp. , 2020. (September 2020)

Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance,M. Baysal, U. Demirci, E. Umit, H. Kirkizlar, E. Atli, H. Gurkan, S. Gulsaran, V. Bas, C. Mail, A. Demir, 10.1038/s41598-020-62885-0, SCIENTIFIC REPORTS, vol. 10, no. 1, pp. , 2020 (April 2020)

27
ATIF

ATIFLAR

Title: Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple Myeloma Author(s): Pasvolsky, O (Pasvolsky, Oren); Ghanem, S (Ghanem, Sassine); Milton, DR (Milton, Denai R.); Masood, A (Masood, Adeel); Tanner, MR (Tanner, Mark R.); Bashir, Q (Bashir, Qaiser); Srour, S (Srour, Samer); Saini, N (Saini, Neeraj); Lin, PL (Lin, Paul); Ramdial, J (Ramdial, Jeremy); Nieto, Y (Nieto, Yago); Lee, HC (Lee, Hans C.); Patel, KK (Patel, Krina K.); Kebriaei, P (Kebriaei, Partow); Thomas, SK (Thomas, Sheeba K.); Weber, DM (Weber, Donna M.); Orlowski, RZ (Orlowski, Robert Z.); Shpall, EJ (Shpall, Elizabeth J.); Champlin, RE (Champlin, Richard E.); Qazilbash, MH (Qazilbash, Muzaffar H.) Source: TRANSPLANTATION AND CELLULAR THERAPY Volume: 29 Issue: 12 Pages: 757-762 DOI: 10.1016/j.jtct.2023.08.031 Published: DEC 2023 Accession Number: WOS:001128725500001 (December 2023)
Title: Prognostic value of t(4;14) translocation in newly diagnosed multiple myeloma patients in novel agent era Author(s): Geng, CY (Geng, Chuanying); Yang, GZ (Yang, Guangzhong); Zhou, HX (Zhou, Huixing); Wang, HJ (Wang, Huijuan); Li, YC (Li, Yanchen); Leng, Y (Leng, Yun); Zhang, ZY (Zhang, Zhiyao); Jian, Y (Jian, Yuan); Chen, WM (Chen, Wenming) Source: HEMATOLOGY Volume: 28 Issue: 1 Article Number: 2161222 DOI: 10.1080/16078454.2022.2161222 Published: DEC 31 2023 Accession Number: WOS:000908182600001 (December 2023)
Record 5 of 10 Title: Role of Conventional Cytogenetics and FISH in the Laboratory Work Up of Plasma Cell Dyscrasias Author(s): Dhabe, A (Dhabe, Aaishwarya); Das, S (Das, Samipa); Parihar, M (Parihar, Mayur) Source: INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY Volume: 44 Issue: 05 Pages: 505-514 DOI: 10.1055/s-0043-1762920 Early Access Date: APR 2023 Published: OCT 2023 Accession Number: WOS:000977252200002 (October 2023)
Title: Molecular genetic aberrations in the pathogenesis of multiple myeloma Author(s): Bong, IPN (Bong, Ivyna Pau Ni); Esa, E (Esa, Ezalia) Source: ASIAN BIOMEDICINE Volume: 17 Issue: 4 Pages: 152-162 DOI: 10.2478/abm-2023-0056 Published: AUG 1 2023 Accession Number: WOS:001087324000002 (August 2023)
Title: Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma Author(s): Bao, A (Bao, Alicia); Zhao, QH (Zhao, Qiuhong); Kudalkar, R (Kudalkar, Ruchi); Rodriguez, J (Rodriguez, Jose); Sharma, N (Sharma, Nidhi); Bumma, N (Bumma, Naresh); Devarakonda, SS (Devarakonda, Srinivas S.); Khan, AM (Khan, Abdullah M.); Umyarova, E (Umyarova, Elvira); Rosko, AE (Rosko, Ashley E.); Benson, D (Benson, Don); Cottini, F (Cottini, Francesca) Source: FRONTIERS IN ONCOLOGY Volume: 13 Article Number: 1216461 DOI: 10.3389/fonc.2023.1216461 Published: JUL 24 2023 Accession Number: WOS:001042232400001 (July 2023)
Title: Clinical relevance of high-risk cytogenetic abnormalities and the second revision of the International Staging System (R2-ISS) in patients with multiple myeloma in clinical practice Author(s): Mizuguchi, M (Mizuguchi, Makiko); Okamoto, Y (Okamoto, Yasunobu); Yagi, H (Yagi, Hikaru); Kagawa, K (Kagawa, Kumiko); Sekimoto, E (Sekimoto, Etsuko); Shibata, H (Shibata, Hironobu); Shigekiyo, T (Shigekiyo, Toshio); Ozaki, S (Ozaki, Shuji) Source: INTERNATIONAL JOURNAL OF HEMATOLOGY Volume: 117 Issue: 5 Special Issue: SI Pages: 718-728 DOI: 10.1007/s12185-023-03541-x Early Access Date: JAN 2023 Published: MAY 2023 Accession Number: WOS:000917800700001 (May 2023)
Title: Current Main Topics in Multiple Myeloma Author(s): More, S (More, Sonia); Corvatta, L (Corvatta, Laura); Manieri, VM (Manieri, Valentina Maria); Olivieri, A (Olivieri, Attilio); Offidani, M (Offidani, Massimo) Source: CANCERS Volume: 15 Issue: 8 Article Number: 2203 DOI: 10.3390/cancers15082203 Published: APR 2023 Accession Number: WOS:000977279900001 (April 2023)
Title: Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor Author(s): Schavgoulidze, A (Schavgoulidze, Anais); Talbot, A (Talbot, Alexis); Perrot, A (Perrot, Aurore); Cazaubiel, T (Cazaubiel, Titouan); Leleu, X (Leleu, Xavier); Manier, S (Manier, Salomon); Buisson, L (Buisson, Laure); Mahéo, S (Maheo, Sabrina); Ferreira, LD (Ferreira, Laura Do Souto); Pavageau, L (Pavageau, Luka); Hulin, C (Hulin, Cyrille); Marolleau, JP (Marolleau, Jean-Pierre); Voillat, L (Voillat, Laurent); Belhadj, K (Belhadj, Karim); Divoux, M (Divoux, Marion); Slama, B (Slama, Borhane); Brechignac, S (Brechignac, Sabine); Macro, M (Macro, Margaret); Stoppa, AM (Stoppa, Anne-Marie); Sanhes, L (Sanhes, Laurence); Orsini-Piocelle, F (Orsini-Piocelle, Frederique); Fontan, J (Fontan, Jean); Chretien, ML (Chretien, Marie-Lorraine); Demarquette, H (Demarquette, Helene); Mohty, M (Mohty, Mohamad); Avet-Loiseau, H (Avet-Loiseau, Herve); Corre, J (Corre, Jill) Source: BLOOD Volume: 141 Issue: 11 Pages: 1308-1315 DOI: 10.1182/blood.2022017863 Early Access Date: MAR 2023 Published: MAR 16 2023 (March 2023)
Title: Impact of Ultra High-risk Genetics on Real-world Outcomes of Transplant-eligible Multiple Myeloma Patients Author(s): Panopoulou, A (Panopoulou, Aikaterini); Easdale, S (Easdale, Sandra); Ethell, M (Ethell, Mark); Nicholson, E (Nicholson, Emma); Potter, M (Potter, Mike); Giotas, A (Giotas, Asterios); Woods, H (Woods, Helena); Thornton, T (Thornton, Tracy); Pawlyn, C (Pawlyn, Charlotte); Boyd, KD (Boyd, Kevin D.); Kaiser, MF (Kaiser, Martin F.) Source: HEMASPHERE Volume: 7 Issue: 2 Article Number: e831 DOI: 10.1097/HS9.0000000000000831 Published: FEB 2023 (February 2023)
Title: Experts' consensus on the definition and management of high risk multiple myeloma Author(s): Marcon, C (Marcon, Chiara); Simeon, V (Simeon, Valentina); Deias, P (Deias, Paola); Facchin, G (Facchin, Gabriele); Corso, A (Corso, Alessandro); Derudas, D (Derudas, Daniele); Montefusco, V (Montefusco, Vittorio); Offidani, M (Offidani, Massimo); Petrucci, MT (Petrucci, Maria Teresa); Zambello, R (Zambello, Renato); Stocchi, R (Stocchi, Raffaella); Fanin, R (Fanin, Renato); Patriarca, F (Patriarca, Francesca) Source: FRONTIERS IN ONCOLOGY Volume: 12 Article Number: 1096852 DOI: 10.3389/fonc.2022.1096852 Published: JAN 23 2023 Accession Number: WOS:000926151700001 (January 2023)
Evaluation of the Mayo Additive Staging System in patients with newly diagnosed multiple myeloma: A real-world analysis Author(s): Chen, HM (Chen, Haimin); Shi, HT (Shi, Haotian); Zhou, N (Zhou, Nian); Yu, WJ (Yu, Wenjun); Wu, LX (Wu, Lixia); Peng, R (Peng, Rong); Wei, W (Wei, Wei); Wang, DJ (Wang, Dongjiao); Zhou, F (Zhou, Fan) Source: EUROPEAN JOURNAL OF HAEMATOLOGY DOI: 10.1111/ejh.13897 Early Access Date: NOV 2022 Accession Number: WOS:000890040700001 PubMed ID: 36366975 ISSN: 0902-4441 eISSN: 1600-0609 (November 2022)
Clinical Features and Outcomes of Patients with Double-Hit/Triple-Hit Multiple Myeloma Detected at Relapse Author(s): Singh, C (Singh, Charanpreet); Panakkal, V (Panakkal, Vandana); Sreedharanunni, S (Sreedharanunni, Sreejesh); Jandial, A (Jandial, Aditya); Jain, A (Jain, Arihant); Lad, D (Lad, Deepesh); Prakash, G (Prakash, Gaurav); Khadwal, A (Khadwal, Alka); Malhotra, P (Malhotra, Pankaj) Source: INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION DOI: 10.1007/s12288-022-01571-9 Early Access Date: SEP 2022 Accession Number: WOS:000862902900001 Author Identifiers: AuthorWeb of Science ResearcherIDORCID Number P, G HGB-5661-2022 ISSN: 0971-4502 eISSN: 0974-0449 (September 2022)
Case Report of Leptomeningeal Myelomatosis and Rapid Improvement with Regimen Consisting of Daratumumab, Pomalidomide, Vincristine, Procarbazine, and Dexamethasone Author(s): Kuan, JW (Kuan, Jew Win); Chai, SL (Chai, Sing Ling); Rajadurai, P (Rajadurai, Pathmanathan); Lau, LG (Lau, Lee Gong); Uchang, J (Uchang, Joseph); Husain, SNAS (Syed Husain, Sharifah Noor Akmal) Source: CASE REPORTS IN HEMATOLOGY Volume: 2022 Article Number: 4081971 DOI: 10.1155/2022/4081971 Published: AUG 31 2022 Accession Number: WOS:000892444400001 PubMed ID: 36092151 Author Identifiers: Author Web of Science ResearcherID ORCID Number Rajadurai, Pathmanathan 0000-0002-9199-1940 ISSN: 2090-6560 eISSN: 2090-6579 (August 2022)
Prognostic Value of Association of Copy Number Alterations and Cell-Surface Expression Markers in Newly Diagnosed Multiple Myeloma Patients Author(s): Dragos, ML (Dragos, Mihaiela L.); Ivanov, IC (Ivanov, Iuliu C.); Mentel, M (Mentel, Mihaela); Vacarean-Trandafir, IC (Vacarean-Trandafir, Irina C.); Sireteanu, A (Sireteanu, Adriana); Titianu, AA (Titianu, Amalia A.); Dascalescu, AS (Dascalescu, Angela S.); Stache, AB (Stache, Alexandru B.); Jitaru, D (Jitaru, Daniela); Gorgan, DL (Gorgan, Dragos L.) Source: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES Volume: 23 Issue: 14 Article Number: 7530 DOI: 10.3390/ijms23147530 Published: JUL 2022 Accession Number: WOS:000831560700001 PubMed ID: 35886877 Author Identifiers: Author Web of Science ResearcherID ORCID Number ivanov, iuliu 0000-0001-5372-9901 VACAREAN - TRANDAFIR, IRINA CEZARA 0000-0002-7329-5431 eISSN: 1422-0067 (July 2022)
Presentation and Impact of Double and Triple hit Cytogenetics in Patients With Multiple Myeloma in the Real World Author(s): Singh, C (Singh, Charanpreet); Panakkal, V (Panakkal, Vandana); Sreedharanunni, S (Sreedharanunni, Sreejesh); Jandial, A (Jandial, Aditya); Jain, A (Jain, Arihant); Lad, D (Lad, Deepesh); Prakash, G (Prakash, Gaurav); Khadwal, A (Khadwal, Alka); Malhotra, P (Malhotra, Pankaj) Source: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA Volume: 22 Issue: 8 Pages: E685-E690 DOI: 10.1016/j.clml.2022.03.005 Early Access Date: JUL 2022 Published: AUG 2022 Accession Number: WOS:000834076800003 PubMed ID: 35422411 Author Identifiers: Author Web of Science ResearcherID ORCID Number Lad, Deepesh AAD-4095-2019 0000-0003-3754-7774 P, G HGB-5661-2022 Malhotra, Pankaj 0000-0003-1198-8491 ISSN: 2152-2650 eISSN: 2152-2669 (July 2022)
The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH) Author(s): Nguyen-Khac, F (Nguyen-Khac, F.); Bidet, A (Bidet, A.); Daudignon, A (Daudignon, A.); Lafage-Pochitaloff, M (Lafage-Pochitaloff, M.); Ameye, G (Ameye, G.); Bilhou-Nabera, C (Bilhou-Nabera, C.); Chapiro, E (Chapiro, E.); Collonge-Rame, MA (Collonge-Rame, M. A.); Cuccuini, W (Cuccuini, W.); Douet-Guilbert, N (Douet-Guilbert, N.); Eclache, V (Eclache, V); Luquet, I (Luquet, I); Michaux, L (Michaux, L.); Nadal, N (Nadal, N.); Penther, D (Penther, D.); Quilichini, B (Quilichini, B.); Terre, C (Terre, C.); Lefebvre, C (Lefebvre, C.); Troadec, MB (Troadec, M-B); Veronese, L (Veronese, L.) Source: LEUKEMIA Volume: 36 Issue: 6 Pages: 1451-1466 DOI: 10.1038/s41375-022-01561-w Early Access Date: APR 2022 Published: JUN 2022 Accession Number: WOS:000782878600001 PubMed ID: 35430613 Author Identifiers: Author Web of Science ResearcherID ORCID Number Ameye, Genevieve 0000-0002-5838-2879 Nguyen-Khac, Florence 0000-0003-3107-6668 ISSN: 0887-6924 eISSN: 1476-5551 (June 2022)
Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted Treatment Author(s): Cerchione, C (Cerchione, Claudio); Usmani, SZ (Usmani, Saad Z.); Stewart, AK (Stewart, A. Keith); Kaiser, M (Kaiser, Martin); Rasche, L (Rasche, Leo); Kortuem, M (Kortuem, Martin); Mateos, MV (Mateos, Maria-Victoria); Spencer, A (Spencer, Andrew); Sonneveld, P (Sonneveld, Pieter); Anderson, KC (Anderson, Kenneth C.) Source: FRONTIERS IN ONCOLOGY Volume: 12 Article Number: 820768 DOI: 10.3389/fonc.2022.820768 Published: FEB 8 2022 Accession Number: WOS:000760627800001 PubMed ID: 35211412 Author Identifiers: Author Web of Science ResearcherID ORCID Number Usmani, Saad Z HCI-4676-2022 0000-0002-5484-8731 Kortum, K. Martin 0000-0002-7011-0286 Kaiser, Martin 0000-0002-3677-4804 ISSN: 2234-943X (February 2022)
Chromosomal 1q21 abnormalities in multiple myeloma: a review of translational, clinical research, and therapeutic strategies Bisht, K; Walker, B; (...); van de Velde, H Dec 2 2021 | Oct 2021 (Early Access) | EXPERT REVIEW OF HEMATOLOGY 14 (12) , pp.1099-1114 (December 2021)
Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatment Gowin, K; Skerget, S; (...); Cowan, AJ Dec 2021 | LEUKEMIA RESEARCH 111 (December 2021)
Lenalidomide, bortezomib and dexamethasone followed by tandem-autologous stem cell transplantation is an effective treatment modality for multi-hit multiple myeloma Tang, SH; Lu, Y; (...); Pei, RZ Nov 2021 | LEUKEMIA RESEARCH 110 (November 2021)
Impact of t(11;14) as a sole and concomitant abnormality on outcomes in multiple myeloma Bal, S; Giri, S; (...); Costa, LJ Oct 2021 | Jun 2021 (Early Access) | BRITISH JOURNAL OF HAEMATOLOGY 195 (1) , pp.112-E116 (October 2021)
Case series: MRD negativity assessment using C-11-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myeloma Ngai, C; Kumar, S; (...); Chim, CS Sep 2021 | THERAPEUTIC ADVANCES IN HEMATOLOGY 12 (September 2021)
A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics Awada, H; Thapa, B; (...); Dhakal, B Aug 2021 | CELLS 10 (8) (August 2021)
Autologous peripheral blood stem cell transplantation as front-line therapy for myeloma with double-hit and triple-hit in a real-world study Yang, GZ; Wang, GR; (...); Chen, WM Aug 20 2021 | CHINESE MEDICAL JOURNAL 134 (16) , pp.1991-1993 (August 2021)
Genetic Predictors of Mortality in Patients with Multiple Myeloma Hassan, H and Szalat, R 2021 | APPLICATION OF CLINICAL GENETICS 14 , pp.241-254 (May 2021)
Malignant plasmacytes in bone marrow detected by flow cytometry as a predictor for the risk stratification system of multiple myeloma Tian, MY; Liu, ZY; (...); Fu, R May 2021 (Early Access) | CYTOMETRY PART B-CLINICAL CYTOMETRY (May 2021)
Novel dual LSD1/HDAC6 inhibitors for the treatment of multiple myeloma Sadhu, MN; Sivanandhan, D; (...); Rajagopal, S Feb 15 2021 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (April 2021)

.M. Baysal, U. Demirci, E. Umit, H. Kirkizlar, E. Atli, H. Gurkan, S. Gulsaran, V. Bas, C. Mail, A. Demir, Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance, 10.1038/s41598-020-62885-0, SCIENTIFIC REPORTS, vol. 10, no. 1, pp. , 2020. (April 2020)

.S. Gulsaran, M. Baysal, U. Demirci, V. Bas, H. Kirkizlar, E. Umit, A. Demir, Late onset left ventricular dysfunction and cardiomyopathy induced with ibrutinib, 10.1177/1078155219852146, JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol. 26, no. 2, pp. 478-480, 2020. (March 2020)

1
ATIF

The Incidence of Venous Thromboembolism and Impact on Survival in Hodgkin Lymphoma, 10.1016/j.clml.2020.02.021, CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol. 20, no. 8, pp. 542-547, 2020. (March 2020)

6
ATIF

ATIFLAR

Title: Platelet Parameters as Biomarkers for Thrombosis Risk in Cancer: A Systematic Review and Meta-analysis Author(s): Malte, AL (Malte, Anne Lind); Hojbjerg, JA (Hojbjerg, Johanne Andersen); Larsen, JB (Larsen, Julie Brogaard) Source: SEMINARS IN THROMBOSIS AND HEMOSTASIS DOI: 10.1055/s-0043-1764381 Early Access Date: MAR 2023 Accession Number: WOS:000952319800001 (March 2023)
Title: Map of thrombogenesis in viral infections and viral-driven tumours Author(s): Neto, BV (Neto, Beatriz Vieira); Tavares, V (Tavares, Valeria); Santos, JMO (Santos, Joana M. O.); Cerqueira, F (Cerqueira, Fatima); Pereira, D (Pereira, Deolinda); Medeiros, R (Medeiros, Rui) Source: DISCOVER ONCOLOGY Volume: 14 Issue: 1 DOI: 10.1007/s12672-022-00610-1 Published: JAN 8 2023 Accession Number: WOS:000912865700001 (January 2023)
Venous thromboembolism and risk stratification in hematological malignancies Author(s): Sanfilippo, KM (Sanfilippo, Kristen M.) Source: THROMBOSIS RESEARCH Volume: 213 Pages: S16-S21 DOI: 10.1016/j.thromres.2022.01.008 Early Access Date: MAY 2022 Supplement: 1 Published: MAY 2022 (May 2022)
rare complication in a child undergoing chemotherapy for Hodgkin lymphoma - multiple cerebral venous sinus thrombosis Author(s): Kostic, A (Kostic, Aleksandar); Jovancic-Petkovic, D (Jovancic-Petkovic, Danijela); Aracki-Trenkic, A (Aracki-Trenkic, Aleksandra); Stojanovic, N (Stojanovic, Nebojsa); Nikolov, V (Nikolov, Vesna) Source: SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO Volume: 150 Issue: 3-4 Pages: 216-219 DOI: 10.2298/SARH201207102K Published: MAR-APR 2022 (March 2022)
Cancer-Associated Thrombosis: A Clinical Scoping Review of the Risk Assessment Models Across Solid Tumours and Haematological Malignancies Mosaad, M; Elnaem, MH; (...); Hin, HS 2021 | INTERNATIONAL JOURNAL OF GENERAL MEDICINE 14 , pp.3881-3897 (August 2021)
Risk Assessment Models for Thrombosis and Anticoagulant-Related Bleeding in Ambulatory Cancer Patients Candeloro, M; Guman, NAM; (...); Di Nisio, M Nov 2021 | Jun 2021 (Early Access) | SEMINARS IN THROMBOSIS AND HEMOSTASIS 47 (08) , pp.972-981 (June 2021)

Invasive fungal infection with a rare organism in a patient with acute myeloid leukaemia, BAYSAL MEHMET, ÜMIT ELIF GÜLSÜM, ÖZDÖVER ALI CANER, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER The National Medical Journal of India, vol. 33, no. 1, pp. 22-23, 2021 (February 2020)

1
ATIF

Polypharmacy and potentially inappropriate medication use in older patients with multiple myeloma, related to fall risk and autonomous neuropathy, 10.1177/1078155219835303, JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol. 26, no. 1, pp. 43-50, 2020. (January 2020)

12
ATIF

ATIFLAR

Definition and prevalence over the years of polypharmacy in Turkey: A systematic review DOI10.29228/jrp.434 JOURNAL OF RESEARCH IN PHARMACY (September 2023)
Factors associated with potentially inappropriate medications in elderly with multiple myeloma DOI10.1177/10781552231190009 JOURNAL OF ONCOLOGY PHARMACY PRACTICE (August 2023)
Health-related quality of life and use of medication with anticholinergic activity in patients with multiple myeloma DOI10.1007/s00520-023-07835-y SUPPORTIVE CARE IN CANCER (July 2023)
Worldwide Prevalence of Polypharmacy: A Systematic Review DOI10.2174/1389200224666230727093010 CURRENT DRUG METABOLISM (June 2023)
Smartphone Apps for Patients With Hematologic Malignancies: Systematic Review and Evaluation of Content Author(s): Gutierrez, NB (Baez Gutierrez, Nerea); Ramallo, HR (Rodriguez Ramallo, Hector); Gonzalez, MF (Fernandez Gonzalez, Marcos); Martin, LAK (Abdel-Kader Martin, Laila) Source: JMIR MHEALTH AND UHEALTH Volume: 10 Issue: 9 Article Number: e35851 DOI: 10.2196/35851 Published: SEP 2022 (September 2022)
Effect of therapeutic regimens and polypharmacy on health-related quality of life of people with multiple myeloma: a cross-sectional study in Belo Horizonte, Brazil Author(s): Malta, JS (Malta, Jessica Soares); Drummond, PLD (de Miranda Drummond, Paula Lana); Silveira, LP (Silveira, Livia Pena); Costa, NL (Costa, Naiane Lima); dos Santos, RMM (Marques dos Santos, Roberta Marcia); Machado, CJ (Machado, Carla Jorge); Reis, AMM (Moreira Reis, Adriano Max); de Padua, CAM (Menezes de Padua, Cristiane Aparecida) Source: CURRENT MEDICAL RESEARCH AND OPINION Volume: 38 Issue: 8 Pages: 1275-1283 DOI: 10.1080/03007995.2022.2034387 Early Access Date: FEB 2022 Published: AUG 3 2022 (August 2022)
Use of fall risk-increasing drugs in older adults with multiple myeloma: A cross-sectional study Author(s): Machado, TRL (Lopes Machado, Taisa Roberta); de Padua, CAM (Menezes de Padua, Cristiane Aparecida); Drummond, PLD (de Miranda Drummond, Paula Lana); Silveira, LP (Silveira, Livia Pena); Malta, JS (Malta, Jessica Soares); dos Santos, RMM (Marques dos Santos, Roberta Marcia); Costa, NL (Costa, Naiane Lima); Reis, AMM (Moreira Reis, Adriano Max) Source: JOURNAL OF GERIATRIC ONCOLOGY Volume: 13 Issue: 4 Pages: 493-498 DOI: 10.1016/j.jgo.2022.01.007 Early Access Date: APR 2022 Published: MAY 2022 (May 2022)
STOPP-START Medication Review: A Non-Randomized Trial in an Indonesian Tertiary Hospital to Improve Medication Appropriateness and to Reduce the Length of Stay of Older Adults Herawati, F; Maharjana, IBN; (...); Susilo, AP Dec 2021 | Jul 2020 (Early Access) | HOSPITAL PHARMACY 56 (6) , pp.668-677 (December 2021)
Frailty assessment in the care of older people with haematological malignancies Goede, V; Neuendorff, NR; (...); Cordoba, R Nov 2021 | LANCET HEALTHY LONGEVITY 2 (11) , pp.E736-E745 (November 2021)
Inappropriate medications and physical function: a systematic review Manias, E; Kabir, MZ and Maier, AB Jul 2021 | THERAPEUTIC ADVANCES IN DRUG SAFETY (July 2021)
Impact of Polypharmacy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Older Adults Sugidono, M; Lo, MM; (...); Olin, RL Apr 2021 | TRANSPLANTATION AND CELLULAR THERAPY 27 (4) (April 2021)
Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders Markov, A; Thangavelu, L; (...); Hassanzadeh, A Mar 18 2021 | STEM CELL RESEARCH & THERAPY 12 (1) (March 2021)

Genetic Diagnosis of Hereditary Hemorrhagic Telangiectasia: Four Novel Pathogenic Variations in Turkish Patients, 10.4274/balkanmedj.galenos.2019.2019.7.2, BALKAN MEDICAL JOURNAL, vol. 37, no. 1, pp. 43-46, 2020. (January 2020)

2
ATIF

.ÜMIT ELIF GÜLSÜM, KORKMAZ ÜLKÜ, BAYSAL MEHMET, KARAMAN GÜLSARAN SEDANUR, BAS VOLKAN, DEMIRCI UFUK, KIRKIZLAR HAKKI ONUR, ALTUN GÜLAY, DEMIR AHMET MUZAFFER, Evaluation of Sarcopenia with F-18 FDG PET/CT and relation with disease outcomes in patients with multiple myeloma, European Journal of Cancer Care, vol. 29, no. 6, pp. 1-7, 2020.

.ALP KIRKIZLAR TUGCAN, AKALIN EMIN HALIS, KIRKIZLAR HAKKI ONUR, ÖZKALEMKAS FAHIR, ÖZKOCAMAN VILDAN, KAZAK ESRA, ÖZAKIN CÜNEYT, BÜLBÜL ESRA NUR, DANACI EZGI SEZEN, ALI RIDVAN, Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia, Leukemia Research, vol. 99, no. 106463, pp. 1-5, 2020.

.Ümit Elif Gülsüm,KORKMAZ ÜLKÜ,BAYSAL MEHMET,KARAMAN GÜLSARAN SEDANUR,BAS VOLKAN,DEMIRCI UFUK,KIRKIZLAR HAKKI ONUR,ALTUN GÜLAY,DEMIR AHMET MUZAFFER, Evaluation of Sarcopenia with F-18 FDG PET/CT and relation with disease outcomes in patients with multiple myeloma, European Journal of Cancer Care, vol. 29, no. 6, pp. 1-7, 2020.

.ÜMIT ELIF GÜLSÜM, BAYSAL MEHMET, BAS VOLKAN, ASKER ISMAIL, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Polypharmacy and potentially inappropriate medication use in older patients with multiple myeloma, related to fall risk and autonomous neuropathy, Journal of Oncology Pharmacy Practice, vol. 26, no. 1, pp. 43-50, 2020.

.BAYSAL MEHMET, DEMIR SELMA, ÜMIT ELIF GÜLSÜM, GÜRKAN HAKAN, BAS VOLKAN, KARAMAN GÜLSARAN SEDANUR, DEMIRCI UFUK, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Genetic Diagnosis of Hereditary Hemorrhagic Telangiectasia: Four Novel Pathogenic Variations in Turkish Patients, Balkan Medical Journal, vol. 37, no. 1, pp. 43-46, 2020.

.BAYSAL MEHMET, DEMIRCI UFUK, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, ATLI EMINE IKBAL, GÜRKAN HAKAN, KARAMAN GÜLSARAN SEDANUR, BAS VOLKAN, Mail Çisem, DEMIR AHMET MUZAFFER, Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance, Scientific Reports, vol. 10, no. 5991, pp. 1-7, 2020.

.KIRKIZLAR HAKKI ONUR, ALP KIRKIZLAR TUGCAN, ÜMIT ELIF GÜLSÜM, ASKER ISMAIL, BAYSAL MEHMET, BAS VOLKAN, KARAMAN GÜLSARAN SEDANUR, DEMIRCI UFUK, DEMIR AHMET MUZAFFER, The Incidence of Venous Thromboembolism and Impact on Survival in Hodgkin Lymphoma, Clinical Lymphoma Myeloma and Leukemia, vol. 20, no. 8, pp. 542-547, 2020.

.KARAMAN GÜLSARAN SEDANUR, BAYSAL MEHMET, DEMIRCI UFUK, BAS VOLKAN, KIRKIZLAR HAKKI ONUR, ÜMIT ELIF GÜLSÜM, DEMIR AHMET MUZAFFER, Late onset left ventricular dysfunction and cardiomyopathy induced with ibrutinib, Journal of Oncology Pharmacy Practice, vol. 26, no. 2, pp. 478-480, 2020.

.M. Baysal, E. Umit, A. Ozdover, O. Kirkizlar, A. Demir, Invasive fungal infection with a rare organism in a patient with acute myeloid leukaemia, 10.4103/0970-258X.308237, NATIONAL MEDICAL JOURNAL OF INDIA, vol. 33, no. 1, pp. 22-23, 2020.

.O. Kirkizlar, T. Kirkizlar, E. Umit, I. Asker, M. Baysal, V. Bas, S. Gulsaran, U. Demirci, A. Demir, The Incidence of Venous Thromboembolism and Impact on Survival in Hodgkin Lymphoma, 10.1016/j.clml.2020.02.021, CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol. 20, no. 8, pp. 542-547, 2020.

.M. Baysal, S. Demir, E. Umit, H. Gurkan, S. Gulsaran, U. Demirci, H. Kirkizlar, A. Demir, V. Ball, Genetic Diagnosis of Hereditary Hemorrhagic Telangiectasia: Four Novel Pathogenic Variations in Turkish Patients, 10.4274/balkanmedj.galenos.2019.2019.7.2, BALKAN MEDICAL JOURNAL, vol. 37, no. 1, pp. 43-46, 2020.

.E. Umit, U. Korkmaz, M. Baysal, S. Karaman Gulsaran, V. Bas, U. Demirci, H. Onur Kirkizlar, G. Durmus Altun, A. Muzaffer Demir, Evaluation of Sarcopenia with F-18 FDG PET/CT and relation with disease outcomes in patients with multiple myeloma, 10.1111/ecc.13318, EUROPEAN JOURNAL OF CANCER CARE, vol. 29, no. 6, pp. , 2020.

.E. Umit, M. Baysal, H. Kirkizlar, A. Demir, Economic analysis of oral posaconazole prophylaxis in acute myeloid leukemia during remission induction in Turkey, 10.14744/nci.2019.89896, NORTHERN CLINICS OF ISTANBUL, vol. 7, no. 3, pp. 222-225, 2020.

Late onset left ventricular dysfunction and cardiomyopathy induced with ibrutinib, 10.1177/1078155219852146, JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol. 26, no. 2, pp. 478-480, 2020. (May 2019)

1
ATIF

.E. Umit, M. Baysal, V. Bas, I. Asker, O. Kirkizlar, A. Demir, Polypharmacy and potentially inappropriate medication use in older patients with multiple myeloma, related to fall risk and autonomous neuropathy, 10.1177/1078155219835303, JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol. 26, no. 1, pp. 43-50, 2020. (March 2019)

Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life, 10.4274/tjh.galenos.2018.2018.0190, TURKISH JOURNAL OF HEMATOLOGY, vol. 36, no. 1, pp. 43-47, 2019. (February 2019)

12
ATIF

ATIFLAR

Title: Medical Therapeutics for the Treatment of Vascular Anomalies: Part 3 Author(s): Ricci, K (Ricci, Kiersten) Source: ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA Volume: 36 Issue: 1 Pages: 125-136 DOI: 10.1016/j.coms.2023.09.013 Early Access Date: NOV 2023 Published: FEB 2024 Accession Number: WOS:001117758200001 (November 2023)
Title: Health-Related Quality of Life Outcome Measures in Individuals With Hereditary Hemorrhagic Telangiectasia: A Scoping Review Author(s): Gong, AJ (Gong, Anna J.); Garg, T (Garg, Tushar); Khalil, A (Khalil, Adham); Gowda, PC (Gowda, Prateek C.); Mathai, SC (Mathai, Stephen C.); Rowan, NR (Rowan, Nicholas R.); Merlo, CA (Merlo, Christian A.); Weiss, CR (Weiss, Clifford R.) Source: AMERICAN JOURNAL OF RHINOLOGY & ALLERGY DOI: 10.1177/19458924231207123 Early Access Date: OCT 2023 Accession Number: WOS:001085592700001 (October 2023)
Title: Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia Author(s): Ielasi, L (Ielasi, Luca); Tonnini, M (Tonnini, Matteo); Piscaglia, F (Piscaglia, Fabio); Serio, I (Serio, Ilaria) Source: WORLD JOURNAL OF HEPATOLOGY Volume: 15 Issue: 5 Pages: 675-687 DOI: 10.4254/wjh.v15.i5.675 Published: MAY 27 2023 Accession Number: WOS:001014644300006 (May 2023)
Hereditary Hemorrhagic Telangiectasia: Genetics, Pathophysiology, Diagnosis, and Management Author(s): Viteri-Noel, A (Viteri-Noel, Adrian); Gonzalez-Garcia, A (Gonzalez-Garcia, Andres); Patier, JL (Patier, Jose Luis); Fabregate, M (Fabregate, Martin); Bara-Ledesma, N (Bara-Ledesma, Nuria); Lopez- Rodriguez, M (Lopez-Rodriguez, Monica); del Olmo, VG (del Olmo, Vicente Gomez); Manzano, L (Manzano, Luis) Source: JOURNAL OF CLINICAL MEDICINE Volume: 11 Issue: 17 Article Number: 5245 DOI: 10.3390/jcm11175245 Published: SEP 2022 (September 2022)
Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for Clinicians Author(s): Al-Samkari, H (Al-Samkari, Hanny) Source: SEMINARS IN THROMBOSIS AND HEMOSTASIS Volume: 48 Issue: 05 Pages: 514-528 DOI: 10.1055/s-0042-1743467 Early Access Date: FEB 2022 Published: JUL 2022 (July 2022)
Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT Author(s): Le, TTT (Thi Thao Truc Le); Martinent, G (Martinent, Guillaume); Dupuis-Girod, S (Dupuis-Girod, Sophie); Parrot, A (Parrot, Antoine); Contis, A (Contis, Anne); Riviere, S (Riviere, Sophie); Chinet, T (Chinet, Thierry); Grobost, V (Grobost, Vincent); Espitia, O (Espitia, Olivier); Dussardier-Gilbert, B (Dussardier-Gilbert, Brigitte); Alric, L (Alric, Laurent); Armengol, G (Armengol, Guillaume); Maillard, H (Maillard, Helene); Leguy-Seguin, V (Leguy-Seguin, Vanessa); Leroy, S (Leroy, Sylvie); Rondeau-Lutz, M (Rondeau-Lutz, Murielle); Lavigne, C (Lavigne, Christian); Mohamed, S (Mohamed, Shirine); Chaussavoine, L (Chaussavoine, Laurent); Magro, P (Magro, Pascal); Seguier, J (Seguier, Julie); Kerjouan, M (Kerjouan, Mallorie); Fourdrinoy, S (Fourdrinoy, Sylvie) Source: ORPHANET JOURNAL OF RARE DISEASES Volume: 17 Issue: 1 Article Number: 281 DOI: 10.1186/s13023-022-02426-2 Published: JUL 19 2022 (July 2022)
Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument Author(s): Kasthuri, RS (Kasthuri, Raj S.); Chaturvedi, S (Chaturvedi, Shruti); Thomas, S (Thomas, Sonia); Vandergrift, N (Vandergrift, Nathan); Bann, C (Bann, Carla); Schaefer, N (Schaefer, Nicole); Clancy, MS (Clancy, Marianne S.); Pyeritz, R (Pyeritz, Reed); McCrae, KR (McCrae, Keith R.) Source: BLOOD ADVANCES Volume: 6 Issue: 14 Pages: 4301-4309 DOI: 10.1182/bloodadvances.2022007748 Early Access Date: JUL 2022 Published: JUL 26 2022 (July 2022)
A precision medicine approach to hereditary hemorrhagic telangiectasia and complex vascular anomalies Author(s): Al-Samkari, H (Al-Samkari, Hanny); Eng, W (Eng, Whitney) Source: JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 20 Issue: 5 Pages: 1077-1088 DOI: 10.1111/jth.15715 Early Access Date: APR 2022 Published: MAY 2022 (May 2022)
Long-term efficacy assessment of current treatment options for epistaxis in HHT Dur, C; Anschuetz, L; (...); Caversaccio, M Nov 2021 | Mar 2021 (Early Access) | EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY 278 (11) , pp.4321-4328 (November 2021)
Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care Al-Samkari, H Feb 18 2021 | BLOOD 137 (7) , pp.888-895 (February 2021)
Pericytes in Hereditary Hemorrhagic Telangiectasia Galaris, G; Thalgott, JH and Lebrin, FPG 2019 | PERICYTE BIOLOGY IN DISEASE 1147 , pp.215-246 (June 2019)
The Impact of Small Bowel Endoscopy in Patients with Hereditary Hemorrhagic Telangiectasia Zammit, SC; Sanders, DS; (...); Sidhu, R Dec 2018 | TURKISH JOURNAL OF HEMATOLOGY 35 (4) , pp.300-301 (February 2019)

.BAYSAL MEHMET, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, OZDOVER ALI CANER, DEMIR AHMET MUZAFFER, Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life, Turkish Journal of Hematology, vol. 36, no. 1, pp. 43-47, 2019.

.E. Umit, M. Baysal, A. Ozdover, O. Kirkizlar, A. Demir, A case of refractory chronic lymphocytic leukaemia with an unusual course, 10.4103/0970-258X.303614, NATIONAL MEDICAL JOURNAL OF INDIA, vol. 32, no. 6, pp. 347-+, 2019.

.M. Baysal, E. Umit, H. Kirkizlar, A. Ozdover, A. Demir, Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life, 10.4274/tjh.galenos.2018.2018.0190, TURKISH JOURNAL OF HEMATOLOGY, vol. 36, no. 1, pp. 43-47, 2019.

.M. BAYSAL, G. E. ÜMIT, O. H. KIRKIZLAR, C. A. OZDOVER, M. A. DEMIR, Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia, Effects on Epistaxis Severity Score and Quality of Life, Turkish Journal of Hematology, 6, 2019.

Baysal M1, Ümit EG1, Kırkızlar HO1, Özdöver AC1, Demir AM1. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia, Effects on Epistaxis Severity Score and Quality of Life (June 2018)

.M. Baysal, E. Umit, I. Boz, O. Kirkizlar, M. Demir, Fusarium Endophthalmitis, Unusual and Challenging Infection in an Acute Leukemia Patient, 10.1155/2018/9531484, CASE REPORTS IN HEMATOLOGY, vol. 2018, pp. , 2018. (April 2018)

The Impact of Mean Platelet Volume (MPV) and JAK-2 Mutation on Thrombosis in Chronic Myeloproliferative Diseases, Indian Journal of Hematology and Blood Transfusion, 6, 2017. (February 2018)

9
ATIF

ATIFLAR

Correlation of Thrombosis and Clinicohematological Parameters with JAK2V617F Mutation in Philadelphia-Negative CMPNs: A Study from India Author(s): Singh, K (Singh, Kanwaljeet); Pradeep, V (Pradeep, V); Ahuja, A (Ahuja, Ankur); Somasundarum, V (Somasundarum, Venkatesan); Mishra, K (Mishra, Kundan); Chatterjee, T (Chatterjee, Tathagat) Source: JOURNAL OF LABORATORY PHYSICIANS Volume: 14 Issue: 04 Pages: 394-397 DOI: 10.1055/s-0042-1757230 Early Access Date: OCT 2022 Published: DEC 2022 (December 2022)
Risk of Cardiovascular and Venous Thromboembolic Events Associated With Janus Kinase Inhibitors in Rheumatoid Arthritis A Systematic Review and Network Meta-analysis Author(s): Alves, C (Alves, Carlos); Penedones, A (Penedones, Ana); Mendes, D (Mendes, Diogo); Marques, FB (Marques, Francisco Batel) Source: JCR-JOURNAL OF CLINICAL RHEUMATOLOGY Volume: 28 Issue: 2 Pages: 69-76 DOI: 10.1097/RHU.0000000000001804 Published: MAR 2022 (March 2022)
Evaluation of the Relationship between Janus Kinase 2 Mutational Burden and Clinical Findings in Adult Myeloproliferative Neoplasm Patients Author(s): Kahraman, CY (Kahraman, Cigdem Yuce); Sincan, G (Sincan, Gulden); Tatar, A (Tatar, Abdulgani) Source: HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI Volume: 60 Issue: 1 Pages: 26-32 DOI: 10.4274/haseki.galenos.2021.7530 Published: JAN 2022 (January 2022)
Sclerostin Depletion Induces Inflammation in the Bone Marrow of Mice Donham, C; Chicana, B; (...); Manilay, JO Sep 2021 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 (17) (September 2021)
Platelets as messengers of early-stage cancer Sabrkhany, S; Kuijpers, MJE; (...); Griffioen, AW Jun 2021 | Feb 2021 (Early Access) | CANCER AND METASTASIS REVIEWS 40 (2) , pp.563-573 (June 2021)
Mean Platelet Volume Has Prognostic Value Chronic Lymphocytic Leukemia Masternak, M; Pula, B; (...); Giannopoulos, K 2020 | CANCER MANAGEMENT AND RESEARCH 12 , pp.9977-9985 (October 2020)
Higher AURKA and PLK1 expression are associated with inferior overall survival in patients with myelofibrosis Galusic, D; Lucijanic, M; (...); Kusec, R Mar 2020 | BLOOD CELLS MOLECULES AND DISEASES 81 (March 2020)
Psoriasis and Psoriatic Arthritis Cardiovascular Disease Endotypes Identified by Red Blood Cell Distribution Width and Mean Platelet Volume Conic, RRZ; Damiani, G; (...); Cooper, KD Jan 2020 | JOURNAL OF CLINICAL MEDICINE 9 (1) (January 2020)
Elevated Neutrophil-to-Lymphocyte-ratio and Platelet-to-Lymphocyte Ratio in Myelofibrosis: Inflammatory Biomarkers or Representatives of Myeloproliferation Itself? Lucijanic, M; Cicic, D; (...); Kusec, R May 2018 | ANTICANCER RESEARCH 38 (5) , pp.3157-3163 (May 2018)

.M. Ayer, M. Ciloglu, F. Sar, E. Ataoglu, F. Ayer, T. Elibol, O. Kirkizlar, Frequency of Paroxysmal Nocturnal Hemoglobinuria Clone in Turkish Myelodysplastic Syndrome Group, 10.4274/haseki.40327, HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, vol. 56, no. 3, pp. 175-180, 2018. (January 2018)

.M. Lucijanic, Z. Mitrovic, D. Cicic, Z. Prka, V. Pejsa, A. Livun, T. Stoos-Veic, Z. Romic, M. Zivkovic, I. Lucijanic, Z. Fabris, R. Kusec, Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis, 10.1007/s12185-017-2348-4, INTERNATIONAL JOURNAL OF HEMATOLOGY, vol. 107, no. 2, pp. 166-172, 2018.

.M. Baysal, E. Umit, A. Ozdover, H. Sutcu, I. Cilingir, O. Kirkizlar, C. Sayin, A. Demir, Acute Promyelocytic Leukemia Diagnosed at the End of First Trimester with a Successful Outcome, 10.14744/ejmo.2018.0028, EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, vol. 2, no. 4, pp. 258-260, 2018.

.E. Umit, M. Baysal, H. Kirkizlar, A. Demir, Splanchnic Venous Thrombosis, with Spotlight on Occult Malignancies, Anticoagulation, and Bleeding, 10.5152/EurJTher.2018.483, EUROPEAN JOURNAL OF THERAPEUTICS, vol. 24, no. 2, pp. 112-114, 2018.

.M. BAYSAL, G. E. ÜMIT, B. I. BOZ, O. H. KIRKIZLAR, M. A. DEMIR, Fusarium Endophthalmitis, Unusual and Challenging Infection in an Acute Leukemia Patient, Case Reports in Hematology, vol. 2018, pp. 1-3, 1, 2018.

The Impact of Mean Platelet Volume (MPV) and JAK-2 Mutation on Thrombosis in Chronic Myeloproliferative Diseases, M. Ayer, I. Menken, M. Yamak, F. Ayer, O. Kirkizlar, M. Aktuglu, 10.1007/s12288-016-0685-8, INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, vol. 33, no. 2, pp. 181-187, 2017 (June 2017)

2
ATIF

.M. Ayer, I. Menken, M. Yamak, F. Ayer, O. Kirkizlar, M. Aktuglu, The Impact of Mean Platelet Volume (MPV) and JAK-2 Mutation on Thrombosis in Chronic Myeloproliferative Diseases, 10.1007/s12288-016-0685-8, INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, vol. 33, no. 2, pp. 181-187, 2017.

1
ATIF

.M. Ayer, M. Aktuglu, H. Acik, E. Bireller, M. Velet, O. Kirkizlar, E. Osmanbasoglu, Z. Karaali, T. Alioglu, N. Yigit, E. Atalay, O. Ure, B. Cakmakoglu, Cox-2 gene polymorphisms in Turkish patients with myelodysplastic syndrome, INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol. 9, no. 6, pp. 10597-10601, 2016.

Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients, 10.4274/tjh.2013.0151, TURKISH JOURNAL OF HEMATOLOGY, vol. 30, no. 4, pp. 351-358, 2013. (December 2013)

1
ATIF

Effectiveness of preoperative plasmapheresis in a pregnancy complicated by hyperthyroidism and anti-thyroid drug-associated angioedema, 10.3109/09513590.2012.754871, GYNECOLOGICAL ENDOCRINOLOGY, vol. 29, no. 5, pp. 508-510, 2013. (May 2013)

7
ATIF

ATIFLAR

Advances in the differential diagnosis of transient hyperthyroidism in pregnancy and Graves' disease Author(s): Guo, N (Guo, Nian); Xue, M (Xue, Meng); Liang, Z (Liang, Zhen) Source: ARCHIVES OF GYNECOLOGY AND OBSTETRICS DOI: 10.1007/s00404-022-06774-z Early Access Date: SEP 2022 (September 2022)
Therapeutic plasma exchange in hyperthyroidism prior to surgery Author(s): Kirkizlar, HO (Kirkizlar, H. O.); Celik, M (Celik, M.) Source: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION DOI: 10.1007/s40618-022-01897-1 Early Access Date: AUG 2022 (August 2022)
Therapeutic plasma exchange for Graves' disease in pregnancy Lumchee, M; Yue, MM; (...); Morton, A Aug 2021 (Early Access) | OBSTETRIC MEDICINE (August 2021)
Thyroidectomy in Pregnant Patient with Grave's Disease Without Response to Medical Treatment: Case Repor Melo, LJR; Ramirez, VC; (...); Madero, AI Jul-sep 2020 | UNIVERSITAS MEDICA 61 (3) (July 2020)
Severe Hyperthyroidism Complicated by Agranulocytosis Treated with Therapeutic Plasma Exchange: Case Report and Review of the Literature Garla, V; Kovvuru, K; (...); Salim, SA 2018 | CASE REPORTS IN ENDOCRINOLOGY 2018 (January 2018)
Graves' Disease Thyrotoxicosis and Propylthiouracil Related Agranulocytosis Successfully Treated with Therapeutic Plasma Exchange and G-CSF Followed by Total Thyroidectomy Candoni, A; De Marchi, F; (...); Fanin, R Oct 16 2017 | MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES 9 (October 2017)
Therapeutic apheresis in pregnancy: General considerations and current practice Marson, P; Gervasi, MT; (...); De Silvestro, G Dec 2015 | TRANSFUSION AND APHERESIS SCIENCE 53 (3) , pp.256-261 (December 2015)

Sticky Platelet Syndrome in Patients with Uninduced Venous Thrombosis, 10.5152/tjh.2011.79, TURKISH JOURNAL OF HEMATOLOGY, vol. 30, no. 1, pp. 48-52, 2013. (March 2013)

10
ATIF

ATIFLAR

new decade awaits sticky platelet syndrome: where are we now, how do we manage and what are the complications? Author(s): Stasko, J (Stasko, Jan); Holly, P (Holly, Pavol); Kubisz, P (Kubisz, Peter) Source: EXPERT REVIEW OF HEMATOLOGY Volume: 15 Issue: 1 Pages: 53-63 DOI: 10.1080/17474086.2022.2030217 Early Access Date: JAN 2022 Published: JAN 2 2022 (January 2022)
Platelet hyperaggregability and venous thrombosis risk: results from the RETROVE project Llobet, D; Vallve, C; (...); Souto, JC Mar 2021 | BLOOD COAGULATION & FIBRINOLYSIS 32 (2) , pp.122-131 (March 2021)
Primary Thrombophilia XIV: Worldwide Identification of Sticky Platelet Syndrome Vallejo-Villalobos, MF; Gomez-Cruz, GB; (...); Ruiz-Arguelles, GJ Jun 2019 | SEMINARS IN THROMBOSIS AND HEMOSTASIS 45 (4) , pp.423-428 (June 2019)
Primary Thrombophilia in Mexico XIII: Localization of the Thrombotic Events in Mexican Mestizos With the Sticky Platelet Syndrome Azamar-Solis, B; Cantero-Fortiz, Y; (...); Ruiz-Arguelles, GJ Apr 10 2019 | CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS 25 , pp.1-4 (April 2019)
Sticky Platelet Syndrome: 35 Years of Growing Evidence Kubisz, P; Holly, P and Stasko, J Feb 2019 | SEMINARS IN THROMBOSIS AND HEMOSTASIS 45 (1) , pp.61-68 (February 2019)
Short closure time values in PFA-100 (R) are related to venous thrombotic risk. Results from the RETROVE Study Vazquez-Santiago, M; Vilalta, N; (...); Souto, JC Sep 2018 | THROMBOSIS RESEARCH 169 , pp.57-63 (September 2018)
Rare thrombophilic conditions Salvagno, GL; Pavan, C and Lippi, G Sep 2018 | ANNALS OF TRANSLATIONAL MEDICINE 6 (17) (September 2018)
Progress in the Understanding of Sticky Platelet Syndrome Sokol, J; Skerenova, M; (...); Kubisz, P Feb 2017 | SEMINARS IN THROMBOSIS AND HEMOSTASIS 43 (1) , pp.8-13 (February 2017)
Sticky platelet syndrome: an important cause of life-threatening thrombotic complications Kubisz, P; Stanciakova, L; (...); Holly, P Jan 2 2016 | EXPERT REVIEW OF HEMATOLOGY (January 2016)
Sticky Platelet Syndrome: History and Future Perspectives Kubisz, P; Ruiz-Arguelles, GJ; (...); Ruiz-Delgado, GJ Jul 2014 | SEMINARS IN THROMBOSIS AND HEMOSTASIS 40 (5) , pp.526-534 (July 2014)

.O. Kirkizlar, M. Kendir, Z. Karaali, U. Ure, G. Ozbay, D. Selcuk, R. Kazancioglu, Acute renal failure in a patient with severe hemolysis, 10.1007/s11255-006-9096-3, INTERNATIONAL UROLOGY AND NEPHROLOGY, vol. 39, no. 2, pp. 651-654, 2007. (January 2007)

6
ATIF

ATIFLAR

Acute kidney injury in a postpartum woman with paroxysmal nocturnal hemoglobinuria: A case report and literature review By: Nishimoto, Masatoshi; Matsui, Masaru; Tsushima, Hideo; et al. HEMODIALYSIS INTERNATIONAL Volume: 22 Issue: 1 Pages: E6-E10 Published: JAN 2018 (January 2018)
Renal involvement in paroxysmal nocturnal hemoglobinuria: an update on clinical features, pathophysiology and treatment By: Kokoris, Styliani I.; Gavriilaki, Eleni; Miari, Aggeliki; et al. HEMATOLOGY Volume: 23 Issue: 8 Pages: 558-566 Published: 2018 (January 2018)
Intratubular Hemoglobin Casts in Hemolysis-Associated Acute Kidney Injury Khalighi, MA; Henriksen, KJ; (...); Meehan, SM Feb 2015 | AMERICAN JOURNAL OF KIDNEY DISEASES 65 (2) , pp.337-341 (February 2015)
In vitro hemocompatibility evaluation of poly (4-hydroxybutyrate) scaffold Liu, YQ; Cai, DM; (...); Yin, SL 2014 | INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE 7 (5) , pp.1233-1243 (September 2014)
Fanconi syndrome and chronic kidney disease in paroxysmal nocturnal hemoglobinuria: effect of eculizumab therapy Moumas, E; Bridoux, F; (...); Touchard, G Oct 2012 | CLINICAL NEPHROLOGY 78 (4) , pp.316-321 (October 2012)
Intravascular Hemolysis and Acute Renal Failure After Mitral and Aortic Valve Repair Concepcion, B; Korbet, SM and Schwartz, MM Nov 2008 | AMERICAN JOURNAL OF KIDNEY DISEASES 52 (5) , pp.1010-1015 (November 2008)

International Articles

Comparison of Hemophagocytic Lymphohistiocytosis Diagnostic Criterias in Malignancy-associated Hemophagocytic Lymphohistiocytosis Patients (December 2022)

10.46310-tjim.1121064-2446228.pdf

.KIRKIZLAR HAKKI ONUR, ALP KIRKIZLAR TUGCAN, DEMIRCI UFUK, KARAMAN GÜLSARAN SEDANUR, BAS VOLKAN, ÜMIT ELIF GÜLSÜM, DEMIR AHMET MUZAFFER, Comparison of Hemophagocytic Lymphohistiocytosis Diagnostic Criteria in Malignancy-Associated Hemophagocytic Lymphohistiocytosis Patients, Turkish Journal of Internal Medicine, no. 4, pp. 180-189, 2022.

Granulomatous inflammation in pulmonary pathology of 2019 novel coronavirus pneumonia: case report with a literature review Usturalı Keskin, E., Tastekin, E., Can, N. et al. Granulomatous inflammation in pulmonary pathology of 2019 novel coronavirus pneumonia: case report with a literature review. Surg Exp Pathol 3, 21 (2020). https://doi.org/10.1186/s42047-020-00071-2 (September 2020)

.M. BAYSAL, U. DEMIRCI, V. BAS, S. G. KARAMAN, G. E. ÜMIT, O. H. KIRKIZLAR, S. BAYSAL, M. A. DEMIR, Could ratio of hemoglobin to red cell distribution width and ratio of absolute lymphocyte count to absolute monocyte count be a prognostic tool in newly diagnosed multiple myeloma patients?, Acta Haematologica Polonica, vol. 51, no. 2, pp. 81-87, 6, 2020. (June 2020)

.BAYSAL MEHMET,DEMIRCI UFUK,BAS VOLKAN,KARAMAN GÜLSARAN SEDANUR,ÜMIT ELIF GÜLSÜM,KIRKIZLAR HAKKI ONUR,baysal serap,DEMIR AHMET MUZAFFER, Could ratio of hemoglobin to red cell distribution width and ratio of absolute lymphocyte count to absolute monocyte count be a prognostic tool in newly diagnosed multiple myeloma patients?, Acta Haematologica Polonica, vol. 51, no. 2, pp. 81-87, 2020.

.USTURALI KESKIN FATMA ELIF, TASTEKIN EBRU, CAN NURAY, USTA INCI, TUNÇBILEK NERMIN, KARABULUT DERYA, KULA OSMAN, KIRKIZLAR HAKKI ONUR, Granulomatous inflammation in pulmonary pathology of 2019 novel coronavirus pneumonia: case report with a literature review, Surgical and Experimental Pathology, vol. 3, no. 1, pp. 1-5, 2020.

.E. F. K. USTURALI, E. TASTEKIN, N. CAN, I. USTA, N. TUNÇBILEK, D. KARABULUT, O. KULA, O. H. KIRKIZLAR, Granulomatous inflammation in pulmonary pathology of 2019 novel coronavirus pneumonia: case report with a literature review, Surgical and Experimental Pathology, vol. 3, no. 1, pp. 1-5, 12, 2020.

.ÜMIT ELIF GÜLSÜM, BAYSAL MEHMET, BAS VOLKAN, GOZE HASAN, ASOGLU VEYSI, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Value of Extracellular High Mobility Group Box 1 (HMGB1) in the Clinical Context of Immune Thrombocytopenia, Journal of Clinical and Experimental Investigations, vol. 10, no. 2, pp. 1-6, 2019.

.UZUNÇAKMAK TUGBA KEVSER, KARADAG AYSE SERAP, KIRKIZLAR HAKKI ONUR, ZEMHERI ITIR EBRU, ÖZLÜ EMIN, AKDENIZ NECMETTIN, Primary Cutaneous Follicle Centre Lymphoma Presenting as a Giant Tumoral Lesion on Scalp, Journal of the Turkish Academy Dermatology, vol. 13, no. 4, pp. 1-3, 2019.

.ÜMIT ELIF GÜLSÜM, BAYSAL MEHMET, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Economic Analysis of Oral Posaconazole Prophylaxis in Acute Myeloid Leukemia During Remission Induction in Turkey, Northern Clinics of Istanbul, 2019.

Mehmet Baysal1, Elif G. Umit1, Ali Caner Ozdover1, Havva Sutcu2, Isil Uzun Cilingir2, Onur Kirkizlar1, Cenk Sayin2, Ahmet Muzaffer Demir1. Acute Promyelocytic Leukemia Diagnosed at the End of First Trimester with a Successful Outcome (October 2018)

.G. E. ÜMIT, M. BAYSAL, O. H. KIRKIZLAR, M. A. DEMIR, Splanchnic Venous Thrombosis, with Spotlight on Occult Malignancies, Anticoagulation, and Bleeding, European Journal of Therapeutics, vol. 24, pp. 112-114, 7, 2018.

.B. M. AKTUGLU, H. ACIK, Y. OZDEMIR, M. AYER, S. E. IPLIK, O. H. KIRKIZLAR, Z. KARAALI, N. YIGIT, M. VELET, B. ÇAKMAKOGLU, The effects of MCP-1A251G and CCR2V641 Gene Polymorphisms in a Group of Turkish Patients with Myelodysplastic Syndrome, Austin Journal of Clinical Medicine, vol. 3, no. 3, pp. 1-3, 3, 2018.

.M. BAYSAL, G. E. ÜMIT, C. A. ÖZDÖVER, H. SUTCU, G. I. Ç. UZUN, O. H. KIRKIZLAR, C. N. SAYIN, M. A. DEMIR, Acute Promyelocytic Leukemia Diagnosed at the End of First Trimester with a Successful Outcome, Eurasian Journal of Medicine and Oncology, vol. 2, no. 4, pp. 258-260, 10, 2018.

International Conference Proceedings

.SEVINDIK ÖMÜR GÖKMEN, ÖZKURT ZÜBEYDE NUR, BOGA CAN, BESISIK SEVGI, ipek yildiz, GEDÜK AYFER, OLGUN AYBÜKE, SALIHOGLU AYSE, HAYDAROGLU SAHIN HANDAN, SÖNMEZ MEHMET, VURAL FILIZ, AKAY OLGA MELTEM, kurt yüksel meltem, MARAL SENEM, EKINCI ÖMER, KIRKIZLAR HAKKI ONUR, TEKINALP ATAKAN, demir nazli, MERTER MUSTAFA, SAYDAM GÜRAY, ALACACIOGLU INCI, YEGIN ZEYNEP ARZU, KASAR MUTLU, MASTANZADE METBAN, ÖZSAN GÜNER HAYRI, P-125: An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy, 18th International Myeloma Workshop, Viyana-AVUSTURYA.

.ÖZ PUYAN FULYA, KARAMAN GÜLSARAN SEDANUR, ÜMIT ELIF GÜLSÜM, USTA INCI, TASTEKIN EBRU, KIRKIZLAR HAKKI ONUR, BINBOGA KURT B, DEMIRCI U, DEMIR AHMET MUZAFFER, Next Generation Sequencing (NGS) in acute myeloid leukaemia: a centre experience, 33rd European Congress of Pathology – Abstracts, vol. 479, no. S1, pp. 115-115.

.ÖZ PUYAN FULYA, BINBOGA BUSEM, DEMIRCI UFUK, KIRKIZLAR HAKKI ONUR, GÜRKAN HAKAN, Myelofibrosis associated acute myeloid leukemia with prominent megakaryocyte proliferation, EAHP 2020 Bone Marrow Workshop Case Submission.

.F. P. ÖZ, B. BINBOGA, U. DEMIRCI, O. H. KIRKIZLAR, H. GÜRKAN, Myelofibrosis associated acute myeloid leukemia with prominent megakaryocyte proliferation, EAHP 2020 Bone Marrow Workshop Case Submission.

.TOMBAK ANIL, PEPEDIL TANRIKULU FUNDA, DURUSOY SALIH SERTAÇ, GÜRKAN EMEL, KAYA ELIF, YAVASOGLU IRFAN, ÖZGÜR MEHTAP, DEVECI BURAK, ÖZCAN MEHMET ALI, TERZI HATICE, OKAY MÜFIDE, SAYINALP NILGÜN, YILMAZ MEHMET, OKAN VAHAP, KIZIKLI ALPEREN, ÖZCAN ÖMER, ÇETIN GÜVEN, DEMIRCIOGLU SINAN, AYDOGDU ISMET, SAYDAM GÜRAY, DAVULCU EREN ARSLAN, ILHAN GÜL, UÇAR MEHMET ALI, ÖZET GÜLSÜM, AKPINAR SEVAL, TURGUT BURHAN, BERBER ILHAMI, KURTOGLU ERDAL, SÖNMEZ MEHMET, BATUR SELIM, YILDIRIM RAHSAN, ÖZKOCAMAN VILDAN, GÜNES AHMET KÜRSAT, SAHIP BIRSEN, ERTOP SEHMUS, AKAY MELTEM, BASTÜRK ABDULKADIR, DOGU MEHMET HILMI, AKDENIZ AYDAN, ÜNAL ALI, SEYHANLI AHMET, FERHANOGLU BURHAN, Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences, Results of a Prospective Multicenter Study. 61st ASH Annual Meeting, Orlando-AMERIKA BIRLESIK DEVLETLERI.

.G. E. ÜMIT, M. BAYSAL, H. GÖZE, V. ASOGLU, C. A. ÖZDÖVER, O. H. KIRKIZLAR, M. A. DEMIR, The Impact Of High Mobility Group Box 1 in the Pathogenesis of Immune Thrombocytopenia, European Hematology Association 23rd Annual Meeting 2018, vol. 1, no. 1, pp. 345-346, Stockholm-ISVEÇ.

.G. E. ÜMIT, M. BAYSAL, O. H. KIRKIZLAR, M. A. DEMIR, Economic analysis of posaconazole prophylaxis in patients with acute myeloid leukemia undergoing remission induction chemotherapy from a hospital management perspective. Poster No: 2126, 59th American Society of Hematology Annual Meeting and Exposition, ATLANTA-AMERIKA BIRLESIK DEVLETLERI.

International Conferences and Symposiums

Sayın Dr. Onur Kirkizlar, 16-19 Eylül 2021 tarihleri arasında online olarak gerçekleştireceğimiz 8th Aegean Hematology Oncology Symposium’una konuşmacı olarak katılmayı kabul etmeniz bizleri onurlandırmıştır. 11:00-12:00 Common Symposium of AHOS with BMSG Chairs: Hayri Ozsan, TR - Anastasia Pouli, GR Debate: Should we Treat all patients upfront with Dara-based therapies? Yes: Onur Kirkizlar, TR No: Sosanna Delimpasi, GR Lecture: Treatment with BiTEs: Is it the new standard for penta-refractory patients? Speaker: Meral Beksac, TR (September 2021)

National Articles

.DEMIRCI UFUK, KARAMAN GÜLSARAN SEDANUR, BAS VOLKAN, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Management of Patients with Factor VII Deficiency in Surgery: Single Center Experience, Erciyes Medical Journal, 2021. (December 2021)

.KIRKIZLAR HAKKI ONUR, ALP KIRKIZLAR TUGCAN, DEMIRCI UFUK, KARAMAN GÜLSARAN SEDANUR, BAS VOLKAN, ÜMIT ELIF GÜLSÜM, DEMIR AHMET MUZAFFER, Ekstranodal Bas Boyun Diffüz Büyük B Hücreli Lenfomalarinin Geriye Yönelik Olarak Degerlendirilmesi ve Nodal Hastalik ile Karsilastirilmasi, LLM Dergi, vol. 5, no. 2, pp. 21-26, 2021. (October 2021)

.DEMIRCI UFUK, KARAMAN GÜLSARAN SEDANUR, BAS VOLKAN, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Ruksolitinib Tedavisinin Aniden Kesilmesi Sonrasinda Post-ET Myelofibrozis Bulgularinda Alevlenme: Akilda Kalmasi Gereken Bir Klinik Tablo, LLM Dergi, vol. 5, no. 2, pp. 52-55, 2021. (October 2021)

.BAYSAL MEHMET, ÜMIT ELIF GÜLSÜM, ÖZTÜRK GÖKHAN, KARAMAN GÜLSARAN SEDANUR, BAS VOLKAN, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Akut Myeloid Lösemide CD11b Ifadesinin Hemostatik Komplikasyonlar ve Tedaviye Yanit ile Iliskisi, Namik Kemal Tip Dergisi, vol. 8, no. 1, pp. 16-21, 2020.

.KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Retrospective Analysis of Chronic Myeloid Leukemia Patients: A Single Institution Experience, LLM Dergi, vol. 3, no. 4, pp. 85-91, 2020.

.BAYSAL MEHMET, BAS VOLKAN, KARAMAN GÜLSARAN SEDANUR, ÖZDÖVER ALI CANER, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, ÖZ PUYAN FULYA, DEMIR AHMET MUZAFFER, Retrospective Evaluation of Patients with Hairy Cell Leukemia: A Decade Experience at a Single Center, Eastern Journal of Medicine, vol. 24, no. 4, pp. 437-440, 2019.

.Akay Fatih Erkan, Koçyigit Beliz, Tan Berfin, ATLI EMINE IKBAL, BAS VOLKAN, KIRKIZLAR HAKKI ONUR, RETROSPECTIVE ANALYSIS OF CHRONIC MYELOID LEUKEMIA PATIENTS IN TRAKYA UNIVERSITY SCHOOL OF MEDICINE, TURKISH MEDICAL STUDENT JOURNAL, vol. 6, no. 3, pp. 70-75, 2019.

.M. AYER, M. Ö. ÇILOGLU, F. SAR, E. H. ATAOGLU, A. F. AYER, T. ELIBOL, O. H. KIRKIZLAR, Frequency of Paroxysmal Nocturnal Hemoglobinuria Clone in Turkish Myelodysplastic Syndrome Group, Haseki Tip Bülteni, vol. 56, no. 3, pp. 175-180, 9, 2018.

National Conference Proceedings

.KIRKIZLAR HAKKI ONUR, Multipl Myelom Tedavisinde Yeni Antikor Ilaç Konjugatlari ve Bispesifik Antikorlar, 13. Ulusal Kemik Iligi Transplantasyonu ve Hu¨cresel Tedaviler Kongresi, pp. 36-37.

.KIRKIZLAR HAKKI ONUR, R/R Waldenström Makroglobulinemisinde Tedavi Seçenekleri, 47. Ulusal Hematoloji Kongresi, pp. 127-128, Antalya-TÜRKIYE.

.DEMIRCI UFUK, BAS VOLKAN, KIRKIZLAR HAKKI ONUR, KARAMAN GÜLSARAN SEDANUR, ÜMIT ELIF GÜLSÜM, DEMIR AHMET MUZAFFER, DIFFÜZ BÜYÜK B HÜCRELI LENFOMA HASTALARINDA CD5 POZITIFLIGININ SAGKALIM VE TEDAVI SEKILLERI ILE ILISKISI, 46. Ulusal Hematoloji Kongresi, pp. 92-93, Antalya-TÜRKIYE.

.KARAMAN GÜLSARAN SEDANUR, BAS VOLKAN, DEMIRCI UFUK, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, ILERI YASTAKI DIFFÜZ BÜYÜK B HÜCRELI NONHODGKIN LENFOMA HASTALARINDA PERFORMANS DEGERLENDIRILMESININ ETKISI, 46. Ulusal Hematoloji Kongresi, vol. 1, no. 1, pp. 43-44, Antalya-TÜRKIYE.

.BAS VOLKAN, ÜMIT ELIF GÜLSÜM, KARAMAN GÜLSARAN SEDANUR, DEMIRCI UFUK, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, DARATUMUMAB KULLANIMINA BAGLI INDIREKT COOMBS POZITIFLIGI GELISEN HASTALARDA TRANSFÜZYON YAKLASIM, 46. Ulusal Hematoloji Kongresi, vol. 1, no. 1, pp. 27-28, Antalya-TÜRKIYE.

.DEMIRCI UFUK, BAS VOLKAN, KARAMAN GÜLSARAN SEDANUR, KIRKIZLAR HAKKI ONUR, ÜMIT ELIF GÜLSÜM, DEMIR AHMET MUZAFFER, DIFFÜZ BÜYÜK B HÜCRELI LENFOMA HASTALARINDA CD5 POZITIFLIGININ SAGKALIM VE TEDAVI SEKILLERI ILE ILISKISI, 46. Ulusal Hematoloji Kongresi, vol. 1, no. 1, pp. 13-14, Antalya-TÜRKIYE.

.BAS VOLKAN, ÜMIT ELIF GÜLSÜM, BAYSAL MEHMET, KARAMAN GÜLSARAN SEDANUR, DEMIRCI UFUK, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, AML HASTALARINDA KEMOTERAPI TOKSISITESI BELIRLENMESINDE KANSER VE YASLANMA ÇALISMA GRUBU (CARG) SKORUNUN ETKILILIGI, 46. Ulusal Hematoloji Kongresi, vol. 1, no. 1, pp. 7-8, Antalya-TÜRKIYE.

.AYTAN PELIN, GEDÜK AYFER, GEMICI ALIIHSAN, KIRKIZLAR HAKKI ONUR, MARAL SENEM, GÜNES AHMET KÜRSAD, TEKINALP ATAKAN, ILTAR UTKU, ÇEKDEMIR DEMET, SEVINDIK ÖMÜR GÖKMEN, ÖZSAN GÜNER HAYRI, KIRK YAS VE ALTI GENÇ MULTIPLE MIYELOM HASTALARININ KLINIKOPATOLOJIK ÖZELLIKLERI: ÇOK MERKEZLI KESITSEL ÇALISMA, 45. Ulusal Hematoloji Kongresi, Antalya-TÜRKIYE.

.AYTAN PELIN, Gedu¨k Ayfer, GEMICI ALIIHSAN, KIRKIZLAR HAKKI ONUR, MARAL SENEM, Gu¨nes¸ Ahmet Ku¨rs¸at, TEKINALP ATAKAN, ILTAR UTKU, C¸ekdemir Demet, SEVINDIK ÖMÜR GÖKMEN, O¨zsan Gu¨ner Hayri, KIRK YAS¸ VE ALTI GENC¸ MULTI?PLE MI?YELOM HASTALARININ KLI?NI?KOPATOLOJI?K O¨ZELLI?KLERI?: C¸OK MERKEZLI? KESI?TSEL C¸ALIS¸MA, 45. Ulusal Hematoloji Kongresi, ANTALYA-TÜRKIYE.

.KIRKIZLAR HAKKI ONUR, TROMBOSIT ALLOIMMÜNIZASYONU YÖNETIMI, 14. Ulusal Aferez Kongresi, Istanbul-TÜRKIYE.

.DEMIRCI UFUK, BAYSAL MEHMET, BAS VOLKAN, KARAMAN GÜLSARAN SEDANUR, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, MULTIPLE MYELOM HASTALARINDA PLATO SÜRECINE ULASMA SÜRESI VE PROGNOSTIK DEGERI, 45. Ulusal Hematoloji Kongresi, pp. 171-172, Antalya-TÜRKIYE.

.AYTAN PELIN,gedük ayfer,gemici ali ihsan,KIRKIZLAR HAKKI ONUR,MARAL SENEM,GÜNES AHMET KÜRSAT,TEKINALP ATAKAN,ILTAR UTKU,ÇEKDEMIR DEMET,SEVINDIK ÖMÜR GÖKMEN,ÖZSAN GÜNER HAYRI, KIRK YAS VE ALTI GENÇ MULTIPLE MIYELOM HASTALARININKLINIKOPATOLOJIK ÖZELLIKLERI: ÇOK MERKEZLI KESITSELÇALISMA, 45. Ulusal Hematoloji Kongresi.

.B. D. ESEN, M. BAYSAL, G. E. ÜMIT, O. H. KIRKIZLAR, M. A. DEMIR, Faktör VII Eksikligi Oan bir Gebenin Yönetimi, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.B. H. ARBAK, M. BAYSAL, G. E. ÜMIT, O. H. KIRKIZLAR, M. A. DEMIR, Rituksimab Kullanimi Sonrasi elisen Bronsiolitis Oblliterans Organize Pnömonisi Olgu Sunumu, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.M. BAYSAL, G. E. ÜMIT, S. BAYSAL, O. H. KIRKIZLAR, M. A. DEMIR, Multiipl Myelom Hastalarinda M Proteini ve Kardiyak Fonksiyonlarin Iliskisi, Ulusal Hematoloji Kongresi 2017, ANTALYA-TÜRKIYE.

.A. TOPAL, M. BAYSAL, G. E. ÜMIT, O. H. KIRKIZLAR, M. A. DEMIR, Gastrointestinal Kanamanin Nadir bir Nedeni: Diffüz Büyük B Hücreli Non Hodgkin Lenfoma, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.G. E. ÜMIT, M. BAYSAL, O. H. KIRKIZLAR, M. A. DEMIR, REMISYON INDÜKSIYONU TEDAVISI ALAN AKUT MYELOIDLÖSEMI HASTALARINDA POSAKONAZOL PROFILAKSISININDOGRUDAN MALIYET ANALIZI, Ulusal Hematoloji Kongresi 2018, -TÜRKIYE.

.M. BAYSAL, G. E. ÜMIT, S. BAYSAL, O. H. KIRKIZLAR, M. A. DEMIR, Philadelphia Negatif Kronik Myeloproliferatif Hastaliklarda MPN-10 Semptom Degerlendirme Ölçegi ve Bulgular ile Iliskisi, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.S. BOZKAYA, M. BAYSAL, G. E. ÜMIT, O. H. KIRKIZLAR, M. A. DEMIR, Primer Özofageal Diffüz Büyük Be Hücreli Lenfoma: Olgu Sunumu, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.F. A. DOGAN, M. BAYSAL, G. E. ÜMIT, O. H. KIRKIZLAR, M. A. DEMIR, Kronik Lenfositer Lösemi ve Primer Biliyer Siroz: Olgu Sunumu, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.B. I. BOZ, M. BAYSAL, M. A. DEMIR, G. E. ÜMIT, O. H. KIRKIZLAR, Hodgkin Lenfoma Iliskili Vanishing Bile duct Sendromu, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.G. E. ÜMIT, M. BAYSAL, Y. DÜRMÜS, O. H. KIRKIZLAR, M. A. DEMIR, Okült Malignite, Antikoagulasyon ve Kanama Yönleri ile Splanknik Venöz Tromboza Bakis, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.M. KUDAY, M. BAYSAL, G. E. ÜMIT, O. H. KIRKIZLAR, M. A. DEMIR, Akut Myeloid Lösemi Seyrinde Gelisen bir Septik Artrit Olgusu, Ulusal Hematoloji 2017, Antalya-TÜRKIYE.

National Conferences and Symposiums

Klinisyen Gözünden PTHL, NOS (Tedavi) Hakkı Onur Kırkızlar, Trakya Üniversitesi, 49. ULUSAL HEMATOLOJİ KONGRESİ ANTALYA (November 2023)

Köln ve New Orleans Sonrası 2022 Lösemi Lenfoma Miyelom Güncellemesi Toplantısı KML (December 2022)

Miyelomda Görülen Renal Komplikasyonların Ayırıcı Tanı ve Tedavisi: (November 2022)

Hakkı Onur Kırkızlar (3).pdf

20 Aralık 2021 tarihinde “Türkiye Kemik İliği Transplantasyon Vakfı” bünyesinde gerçekleşecek olan “Plazma Hücre Tedavilerinde Kongre Güncellemeleri Toplantısı” bilimsel oturumuna sizi konuşmacı olarak davet etmekten onur duyarız. 20 Aralık 2021 Pazartesi Görev: Konuşmacı Oturum Başkanı: Dr. Hayri Özsan Saat: 18:35 – 19:00 Soru-Cevap: 19:00 – 19:15 Konu: BITE Tedavilerinde Güncel Gelişmeler (December 2021)

Lösemi Lenfoma Miyelom Derneği tarafından 24-25 Aralık 2021 tarihlerinde llmguncelleme2021.dijitalkongre.com adresi üzerinden web tabanlı olarak “2021 Biterken Lösemi Lenfoma Miyelom Güncellemesi” toplantısı düzenlenecektir. Lenfoma Oturumu-4 Kolaylaştırıcı ve Tartışmacılar: Prof. Dr. Meltem Aylı, Prof. Dr. Simten Dağdaş Akalın 16:00-16:20 Konu: Hodgkin Lenfoma Konuşmacı: Yrd. Doç. Dr. Onur Kırkızlar (December 2021)

08-09-10 Ekim 2021 tarihinde Sheraton Grand Adana Hotel’de gerçekleştirilecek “Hematoloji Uzmanlık Derneği 2. Ulusal Kongresi”ne konuşmacı olarak katılmayı kabul ettiğiniz için teşekkür ederiz. 15.10 - 15.30 TP53 Mutasyonlu AML: Yeni Ufuklar Hakkı Onur Kırgızlar (October 2021)

Türk Hematoloji Derneği, 2-3 Nisan 2021 tarihleri arasında ‘13. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi’ni sanal olarak düzenleyecektir. Sizi ‘Multipl Myelom Tedavisinde Yeni Antikor İlaç Konjugatları ve Bispesifik Antikorlar’ konusunda konuşmacı olarak 13. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi’ne davet etmekten onur duyarız. Oturumunuzla ilgili detaylar aşağıda bilgilerinize sunulmuştur. Tarih : 3 Nisan 2021 Oturum Saati : 14:45-16:15 Oturum Adı : Multipl Myelom Oturumu Konu Başlığı : Multipl Myelom Tedavisinde Yeni Antikor İlaç Konjugatları ve Bispesifik Antikorlar (April 2021)

Türk Hematoloji Derneği, 28 Ekim - 31 Ekim 2020 tarihleri arasında “46. Ulusal Hematoloji Kongresi“ni sanal olarak düzenleyecektir. Sizi ‘Plazma Hücre Hastalıkları Multipl Myelom Olgu Paneli’ konusunda konuşmacı olarak 46. Ulusal Hematoloji Kongresi’ne davet etmekten onur duyarız. Oturumunuzla ilgili detaylar aşağıda bilgilerinize sunulmuştur. Tarih : 28 Ekim 2020 Oturum Saati : 15:30-17:00 Oturum Adı: : Plazma Hücre Hastalıkları Multipl Myelom Olgu Paneli Konu Başlığı : Olgu Sunumu (October 2020)

Sayın Dr. H. Onur KIRKIZLAR, 22 – 23 Kasım 2019 tarihleri arasında Marriott Asia Hotel İstanbul ‘ da gerçekleşecek olan “14. ULUSAL AFEREZ KONGRESİ” bilimsel oturumunda konuşmacı olarak sizi davet etmekten onur duyarız. Görev : Konuşmacı Konu: Trombosit Alloimmunizasyonu Yönetimi Tarih: 22 Kasım Cuma 2019 (November 2019)

Türk Hematoloji Derneği, ‘’45. Ulusal Hematoloji Kongresi”ni 30 Ekim - 2 Kasım 2019 tarihleri arasında Titanic Deluxe Belek Otel, Antalya’da düzenleyecektir. Sizi “3 Olgu ile Relaps/Refrakter MM'ye Yaklaşım” konusunda konuşmacı olarak kongremize davet etmekten onur duyuyoruz. Bilgi ve deneyimlerinizi Ulusal Kongremizde paylaşmanızdan mutluluk duyacağız. Bilimsel program detayları aşağıda bilgilerinize sunulmuştur. Oturum Tarihi : 31 Ekim 2019 Oturum Saati : 16:00-17:30 Oturum Başlığı : Myelom Oturumu Oturum Konu Başlığı: 3 Olgu ile Relaps/Refrakter MM'ye Yaklaşım (October 2019)

8. Ulusal Geriatrik Hematoloji Kongresi 27-29 Eylül 2019 tarihleri arasında, Ankara Üniversitesi Morfoloji Binası, Ankara’da gerçekleştirilecektir. Kongremizde konuşmacı olarak görev almayı kabul etmeniz bizi onurlandırmıştır. Oturum detaylarınız aşağıda bilgilerinize sunulmuştur. (September 2019)

Sizi Sözlü Sunu Oturum Başkanı olarak 11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi’ne davet etmekten onur duyarız. Oturumunuzla ilgili detaylar aşağıda bilgilerinize sunulmuştur : Tarih : 01.03.2019 Oturum Saati : 18:45-19:45 (March 2019)

Klinisyen Gözünden PTHL, NOS (Tedavi) Hakkı Onur Kırkızlar, Trakya Üniversitesi, Edirne

Master`s Theses Advised

KLİNİĞİMİZDE TANI KOYULAN VE TAKİP EDİLEN KRONİK LENFOSİTER LÖSEMİ TANILI HASTALARIN GÜNCEL KILAVUZLAR EŞLİĞİNDE EPİDEMİYOLOJİK VERİLERİNİN VE SAĞKALIMLARININ GERİYE DÖNÜK OLARAK İNCELENMESİ. Dr. Mehmet Uygar AVCI (December 2022)

Editorial Positions

Taylor Ayırıcı Tanı El Kitabı. Güneş Tıp Kitapevleri. 2018. ISBN: 978-975-277-684-5 (January 2018)

Referee Positions

Update on the Outcome of M-Protein Screening Program of Multiple Myeloma in China: A 7-Year Cohort Study Cancer Medicine (December 2023)

Prediction Model and Risk Factors for Venous Thromboembolism in Non-Hodgkin Lymphoma: An Analysis of Influencing Factors Technology in Cancer Research & Treatment (November 2023)

Enhanced Clinical Outcomes with Radiotherapy in Diagnostically Challenging Intracranial Plasmacytomas: Analysis of 162 Cases Cancer Medicine (October 2023)

The der(1;7)(q10;p10) defining a distinct profile from -7/del(7q) in Myelodysplastic syndromes Cancer Medicine (August 2023)

The quantitative parameters based on marrow metabolism derived from synthetic MRI: A pilot study of prognostic value in participants with newly diagnosed multiple myeloma Cancer Medicine (August 2023)

The impact of MYD88 and PIM1 in mature large B-cell non-Hodgkin's lymphomas - Defining element of their evolution and prognosis Medicine (August 2023)

Prognostic significance and the correlation between their expression of co-mutated genes in hematological malignancies, detected by next-generation sequencing Cancer Medicine (April 2023)

CT-defined body composition as a prognostic factor in multiple myeloma Hematology (February 2023)

Hemolytic uremic syndrome following the Aluminum phosphide poisoning: a case report" for Journal of Medical Case Reports (January 2022)

Verified review of "Impact of Demographics and Location On Cytogenetics Of Multiple Myeloma In Eastern North Carolina" for Cancer Reports (November 2021)

Verified review of Primary diffuse large B-cell lymphoma of the prostate: a case report and review of the literature for Journal of Medical Case Reports (October 2021)

Verified review of "Polisitemia Vera ve Esansiyel Trombositemide Prognostik Nutrisyonel İndeks ve Sarkopeninin Değerlendirilmesi" for Cerrahpaşa Medical Journal (August 2021)

BalkMedJ-2018-0356 entitled "Investigation of Gene Expressions of Myeloma Cells in the Bone Marrow of Multiple Myeloma Patients by Transcriptome Analysis" for Balkan Medical Journal (April 2018)

BalkMedJ-2017-1244 entitled "Cytotoxic Effects of Some Flavonoids and imatinib on K562 Chronic Myeloid Leukemia Cell Line: data analysis using the combination index method." for the Balkan Medical Journal. (February 2018)

Projects

.BGB-3111-306: Daha önce tedavi edilmemis Mantle Hücreli Lenfomasi olan ve Kök Hücre Nakline uygun olmayan hastalarda Zanubrutinib (BGB-3111) arti Rituximab tedavisinin Bendamustine arti Rituximab tedavisiyle karsilastirmali Faz 3, Randomize, Açik Etiketli, Çok Merkezli Çalisma, 2022.

.ACE-LY-312 (D8227C00001): Daha Önce Tedavi Edilmemis Germinal Merkez Disi Diffüz Büyük B-Hücreli Lenfomasi Olan 65 Yas Gönüllülerde Acalabrutinib ile Birlikte Uygulanan Rituksimab, Siklofosfamid, Doksorubisin, Vinkristin ve Prednizon (R CHOP) ile Faz 3, Randomize, Çift Kör, Plasebo Kontrollü Çalisma, 2021.

.CMBG453B12301. IPSS -R' ye göre orta, yu¨ksek veya çok yu¨ksek riskli miyelodisplastik sendromu veya Kronik Miyelomonositik Lösemi -2'si (KMML-2) olan hastalarin tedavisinde azasitidinin MBG453 ile birlikte ya da MBG453 olmaksizin kullanimina iliskin randomize, çift kör , plasebo kontrollu¨, faz lll, çok merkezli çalisma, 2020.

Other

For all time 7 H-index 125 Sum of Times Cited 46 Publications 40 Publications in Web of Science

onurkirkizlar_WebOfScience_Researcher_CV_20230209.pdf

WEB OF SCIENCE DOCUMENTS 33 TOTAL TIMES CITED 71 H-INDEX 5 AVERAGE CITATIONS PER DOCUMENT 2.1 AVERAGE CITATIONS PER YEAR 4.7 (December 2021)

.AKPINAR SEVAL, TEKGÜNDÜZ EMRE, Hematolojik Kanserlerde Hedefe Yönelik Tedaviler, Türkiye Klinikleri, Ankara-TÜRKIYE.

.KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Tu¨rkiye Klinikleri HEMATOLOJI ÖZEL Hodgkin Lenfoma, Türkiye Klinikleri, Ankara-TÜRKIYE.

.SEVINDIK ÖMÜR GÖKMEN, ÖZSAN GÜNER HAYRI, Günes Ahmet Kürsad, Gemici Ali Ihsan, TEKINALP ATAKAN, Gedük Ayfer, ÖZLÜ CAN, ÇEKDEMIR DEMET, Saribacak Can Esra, KIRKIZLAR HAKKI ONUR, Sirinoglu Demiriz Itir, ERMANTAS NILAY, AYTAN PELIN, Maral Senem, Malkan Ümit Yavuz, Aslan Vedat, Multipl Myelom Tani ve Tedavi Kilavuzu - Editör - Ömür Gökmen Sevindik, Galenos Yayinevi, Ankara-TÜRKIYE.

.H. G. ÖZSAN, G. Ö. SEVINDIK, K. A. GÜNES, I. A. GEMICI, A. TEKINALP, A. GEDÜK, C. ÖZLÜ, D. ÇEKDEMIR, E. C. SARiBACAK, O. H. KIRKIZLAR, I. D. SIRINOGLU, N. ERMANTAS, P. AYTAN, S. MARAL, Y. Ü. MALKAN, V. ASLAN, Multipl Myelom Tani ve Tedavi Kilavuzu, Ulusal, Basim Türü: Basili+Elektronik, TÜRKIYE-, ISBN978-605-80353-4-8, Galenos Yayinevi, 20203. Basim.

.E. Umit, M. Baysal, O. Kirkizlar, A. Demir, Economic Analysis of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Undergoing Remission Induction Chemotherapy from a Hospital Management Perspective, BLOOD, vol. 130, pp. , 2017.

» Educational Qualifications

High School » Graduated in 1996

Bachelor`s Degree » Graduated in 2002

Master`s Degree » Graduated in 2008

Doctoral Degree » Graduated in 2012

» Academic Titles

Assistant Professor $, Medicine » In 2017

Assistant Professor $, Medicine » In 2020

Associate Professor $, Doctor of Medicine » In 2023

» Publications

SCI-SSCI or SCI Expanded Articles

International Articles

International Conference Proceedings

International Conferences and Symposiums

National Articles

National Conference Proceedings

National Conferences and Symposiums

Master`s Theses Advised

Editorial Positions

Referee Positions

Projects

Other